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The outcome of the infection by Mycobacterium tuberculosis (Mtb) depends greatly on how
the host responds to the bacteria and how the bacteria manipulates the host, which is
achieved through protein-protein interactions. This project aims to predict protein inter-
actions between human and Mtb. The interologs method based on experimentally verified
intra-species and inter-species interactions was used to predict human-Mtb protein interac-
tions. They were further filtered using known host-pathogen interactions and genes that are
differentially expressed during infection. This yielded a total of 190 interactions. Analysis of
the subcellular location of the human-Mtb interactions showed that they are potentially fea-
sible. The biological processes of the predicted human proteins suggested their involvement
in apoptosis and production of nitric oxide, whereas those of the Mtb proteins were rele-
vant to the intracellular environment of Mtb in the host. Mapping the proteins onto KEGG
pathways highlighted proteins belonging to the tuberculosis pathway and also suggested that
Mtb proteins might use the host to acquire nutrients. Finally, the predicted interacting Mtb
proteins were enriched in previously predicted drug targets. Taken together, the predicted
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Tuberculosis is an infectious disease that has plagued humans for thousands of years. In-
deed, examination of ancient mummies from Egypt showed signs of tuberculosis [94]. In the
1700s and early 1800s, tuberculosis was the largest cause of death in Western Europe and
the United States. It is still a deadly disease worldwide. Tuberculosis is one of the top three
disease killers alongside HIV/AIDS and malaria. According to the World Health Organiza-
tion (WHO), tuberculosis affects one-third of the world’s population and 1.7 million people
died from it in 2009 [143].
1.1 Tuberculosis transmission
Tuberulosis (TB) is an airborne disease caused by a bacterium called Mycobacterium tubercu-
losis (Mtb). The bacilli enter the body via the respiratory tract by inhalation of contaminated
droplets from people who have an active Mtb infection. In very young children and people
with a weakened immune system, the organisms can grow and multiply immediately, caus-
ing primary tuberculosis. Up to 50% of the time the infection is cleared through a robust
innate immune response and the host does not develop disease. The surviving bacilli are
engulfed by alveolar macrophages and dendritic cells and can remain alive in those cells in
a dormant state. In 10% of cases, the bacilli start to multiply and cause active disease. It
generally happens to immunocompromised individuals such as HIV/AIDS infected people.
In the remaining 90%, the bacilli remain inactive and will not cause any further problems
[2].
Although residing mainly in the lungs causing pulmonary TB when active, the bacteria can










1.2. Tuberculosis diagnostic and treatment 2
miliary TB. The kidneys and lymph nodes are the most common sites for extra-pulmonary
TB. Tuberculosis can also affect the pleura, liver, spleen, bones and joints, heart, brain,
genital organs, meninges, peritoneum and skin [121].
Tuberculosis transmits only from person to person. Persons with active tuberculosis contam-
inate the air when they expel bacteria by coughing, sneezing, or even speaking. The bacteria
are able to survive in the air for several hours. Another person breathing them in may then
become infected. However, a person who has latent TB does not expel bacteria into the air
and therefore, cannot spread the disease. The most common symptom of tuberculosis is a
cough, but patients may also have cold sweats, with or without fever, weight loss, chest pain
and respiratory insufficiency.
1.2 Tuberculosis diagnostic and treatment
Diagnosis of tuberculosis includes chest x-ray, the tuberculin skin test, or examination and
culture of sputum samples. The tuberculin skin test, also known as Mantoux or purified
protein derivative (PPD) test can detect latent infection. However, BCG vaccination can
also lead to a positive test, making PPD a less trusted method [113]. Microscopic detec-
tion of bacteria using sputum samples gives faster results but is less accurate than culture.
Traditional cultures actually take many weeks to give results because of the slow growth
of the bacteria. Molecular techniques detecting antimicrobial resistance markers in samples
or culture are also available, giving results within 24 hours. Rapid and reliable diagnostic
methods are expensive and therefore used only in developed countries. There is still a need
to develop faster and less expensive tests to confirm TB cases.
Tuberculosis is a curable disease but the treatment takes time. Treatment of active tubercu-
losis consists of a combination of first-line drugs for two months followed by the combination
of isoniazid and rifampicin for four months. First-line drugs include isoniazid, rifampicin,
streptomycin, pyrazinamide and ethambutol [95]. The therapy must not be interrupted
even if the patient feels well because the bacilli are not completely eliminated and failure
to comply contributes to the development of drug resistance. In order to ensure that the
treatment is fully completed, the WHO implemented a program called DOTS (directly ob-
served treatment short-course) where patients are observed when they take their pills [96].
The treatment is extended when there is resistance to at least rifampicin and isoniazid, and
the use of second-line drugs is required. This characterizes multi-drug resistant tuberculo-
sis or MDR-TB. Extensively drug-resistant tuberculosis or XDR-TB is defined as MDR-TB
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(amikacin, kanamycin or capreomycin) [64]. MDR and XDR-TB need more complicated and
costlier treatment. Three cases of totally drug-resistant tuberculosis (TDR-TB), a form that
is resistant to all prescribed medications, have also been reported. The first case involved
two patients in Italy in 2007 [89], the second involved fifteen patients in Iran in 2009 [137].
The latest case has been discovered in India in 2011 [132].
1.3 Mycobacterium tuberculosis
Discovered in 1882 by Robert Koch, a German physician and bacteriologist, Mycobacterium
tuberculosis (Mtb) is an obligate human pathogen belonging to the genus Mycobacterium
(M.). It is a rod-shaped, non-motile, non-sporing, aerobic and acid fast bacillus with a size
varying from 0.3 to 0.6 µm in diameter and from 1 to 4 µm in length. The bacillus slowly
replicates with a generation time of about 24 hours [42]. Although staining with difficulty
with crystal violet, Mtb is classified as a Gram-positive bacteria. It has a unique cell wall
composition consisting of mycolic acids linked to underlying arabinogalactan and peptidogly-
can. This cell wall also contains different types of uniqu lipids such as lipoarabinomannan
(LAM), lipomannan (LM) and phosphatidyl-myo-inositol mannosides (PIM). These lipids
appear to play an important role in the virulence of Mtb [66]. Several lipoproteins and gly-
coproteins, such as lpqH (19 kDa), pstS1 (38 kDa), and lprG (Rv14llc) are also found in the
cell wall, where they manipulate bactericidal mechanisms and play a role in the virulence of
Mtb [149, 52].
1.3.1 Mycobacterial strains
The Mtb complex includes M. tuberculosis, M. bovis, causing tuberculosis in cattle, M. bovis
BCG, M. africanum, M. microti, affecting voles [50], and M. pinnipedii, found in seals and sea
lions [35]. Most of the time, human tuberculosis is caused by Mtb, although M. bovis, can also
cause tuberculosis in human. M. tuberculosis consists of six main strain lineages associated
with particular geographic regions: the Indo-Oceanic lineage is mainly found all around the
Indian Ocean; the East-Asian strain lineage occurs in East Asia, Russia and South Africa;
the East-Africa-Indian strain lineage is mainly found in the Indian subcontinent and in East
Africa, the Euro-American strain lineage, in Europe and the Americas; and the West-African
strain lineages, consisting of two lineages, occur almost exclusively in West Africa [51]. Mtb
strains vary in phenotype, virulence and immunogenicity [51].
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Function Number of genes
Virulence, detoxification, adaptation 99
Lipid metabolism 233
Information pathways 229
Cell-wall and cell processes 708
Stable RNAs 50
Insertion sequences and phages 149
PE and PPE proteins 170
Intermediary metabolism and respiration 894
Proteins of unknown function 272
Regulatory proteins 189
Conserved hypothetical proteins 1051
Table 1.1: Functional classification of H37Rv genes
widely studied Mtb strains. The H37 strain was isolated from a human patient in 1905 and
later dissociated into an avirulent strain (H37Ra) and a virulent strain (H37Rv) [73]. The
strain CDC1551 or “Oshkosh” strain was isolated from a 21-year-old male clothing factory
worker located in the Kentucky/Tennessee region (US). Valway et al. [134] showed that this
strain was highly contagious, the index patient infected approximately 80% of his co-workers
and social contacts. They also demonstrated that the CDC1551 strain was highly virulent
in mice: after 20 days of infection, mice infected with the CDC1551 strain presented 100
times higher numbers of bacilli in their lungs than those infected with the Erdman strain.
1.3.2 The Mtb genome
The genome of the H37Rv strain was sequenced in 1998 by Cole et al. at the Sanger Centre
(Hinxton, UK) [33]. The sequence initially contained 4, 411, 529 base pairs (bp), with a G +
C content of 65.6%. They identified 3,974 genes including 3,924 protein-coding genes and 50
genes encoding stable RNA. 40% of the predicted proteins were functionally annotated, some
information or similarities were found for another 44% and 60% had no known functions.
Upon re-annotation of the genome in 2002, 82 additional genes have been included, four
sequencing errors have been corrected, changing the sequence length to 4, 411, 532 bp [26],
and 52% of the proteome (2,058 proteins) has been annotated. Table 1.1 shows the functional
classification of the H37Rv genes after re-annotation.
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coding capacity of the genome [33]. These are the PE and PPE gene families that are
found in mycobacteria only. They were so named because of the motifs Pro–Glu (PE) and
Pro–Pro–Glu (PPE) found near the start of their encoded proteins [33]. These proteins are
thought to play a role in evasion of host immune responses [33, 68].
In 2002, Fleischmann et al. at The Institute for Genomic Research (TIGR) sequenced the
genome of the Mtb CDC1551 strain and compared it to that of the H37Rv strain [48]. They
found that out of the 37 insertions contained in the H37Rv strain relative to strain CDC1551,
8 are complete open reading frames (ORFs). The CDC1551 strain contained 49 insertions
relative to the H37Rv, 17 of them are complete ORFs. They also found that H37Rv contains
16 copies of IS6110, whereas CDC1551 had only 4 copies. IS6110 is an IS3-type insertion
sequence and principal epidemiological marker for Mtb. They identified regions differing in
the copy number of several genes between the two strains. They also identified 1,075 single-
nucleotide polymorphisms (SNPs) between the two genomes. The CDC1551 strain has a
genome size of 4,403,837 bp, an average G + C content of 65.6% and 4,189 coding genes.
1.3.3 Mtb and the immune response
The immune response protects the host against infection, and comprises the innate immune
system and the adaptive immune system. The innate immune response is the first line of de-
fence of the body against pathogens, providing immediate defence against infection. Several
receptors on the surface of the phagocytes (macrophages and dendritic cells) recognize Mtb.
These receptors include the complement receptors, the mannose receptor (MR), dendritic
cell-specific intercellular adhesion molecule-3 (ICAM-3)-grabbing non-integrin (DC-SIGN)
(CD209), surfactant protein A (Sp-A) receptor, the class A scavenger receptor, the toll-like
receptor (TLR) and mannose-binding lectin (MBL) [70]. Thus, the response depends on the
specific receptor that helps a phagocyte ingest Mtb. If the receptor is a signalling pathogen
recognition receptor (PRR) such as TLR or NOD-like receptor (NLR), the binding leads
to the induction of an inflammatory response [130]. Binding to TLRs induce signalling
cascades, most commonly NF-κB and MAPK pathways. Activation of the MAPK path-
ways occurs through a series of phosphorylation. MAP kinase kinase kinase (MKKK) first
phosphorylates MAP kinase kinase (MKK), which in turn phosphorylates MAPK. MAPK
then translocates to the nucleus where it activates by phosphorylation proteins required
for inflammatory responses and apoptosis. For the NF-κB pathway, TLR stimulation also
leads to phosphorylation events which activate the IκB kinase kinase (IKK) complex. IKK
phosphorylates the α subunit of inhibitor of NF-κB (IκB), which is polyubiquitinated and
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genes required for pro-inflammatory responses, such as cytokines and chemokines, and genes
involved in cell proliferation [130].
On the other hand, if the receptor is an endocytic PRR such as MR, the binding leads to
phagocytosis [118], which is the process by which many cells ingest microbial pathogens and
apoptotic or necrotic corpses [112]. Microbes are engulfed into a vacuole called the phago-
some, which then undergoes a maturation process beginning with recruitment of activated
Rab5, which is a GTPase. Activated Rab5 is necessary for maturation of the phagosome
through the recruitment of a large number of effector proteins: the phosphatidyl 3-kinase
(PI3K) hVPS34 that produces phosphatidylinositol-3-phosphate (PI3P) at the phagosome
surface, which in turn recruits proteins containing PI3P motifs, including the early endo-
somal antigen 1 (EEA1), essential for fusion between early endocytic vesicles [4]. Rab5 is
replaced by Rab7 in a process called Rab conversion, which mediates the conversion of the
early endosome to late endosome. This is required for the fusion of the phagosome with the
lysosome to form a phagolysosome. The phagolysosome is an acidic environment enriched
in proteases, and conditions that promote bacterial degradation [4]. Meanwhile, the α and
β chain of MHC (major histocompatibility complex) class II, along with the invariant chain
(Ii or CD74) of the molecules are synthesized and assembled in the endoplasmic reticulum
(ER), transported to the golgi apparatus, and from there to the phagolysosome. Once in the
phagolysosome, the invariant chain is cleaved leaving a small peptide, the class-II associated
invariant chain peptides or CLIP, bound to the class II molecule. HLADM, a vesicle mem-
brane protein, catalyzes the removal of the CLIP peptide from the peptide binding groove
of the MHC molecule and the binding of the pathogen-derived peptides. The MHC class
II-Antigen complex is then transported to cell surface where it can be recognized by the
antigen receptors of CD4+T cells. Bacterial proteins processed in the cytosol by the protea-
some are presented by MHC class I molecules to CD8+ T cells. The transporter associated
with antigen processing (TAP) translocates the peptides generated by the proteasome into
the ER lumen, where MHC class I molecules fold and assemble. The peptides bind to the
MHC class I molecules and the MHC class I-Antigen complex is transported to the plasma
membrane [61]. CD4+ cells help to amplify the host immune response by activating effector
cells and recruiting additional immune cells to the site of disease [119]. CD8+ cells secrete
cytokine and lyse infected cells.
The adaptive immune response is activated after two to three weeks of infection. The inter-
action between Mtb and cells of both the innate and adaptive immune system results in the
secretion of chemokines and cytokines, the most important being tumor necrosis factor-α
(TNFα), cytokines of the interleukin-1 family (IL-1β, IL-18), IL-12, and IFNγ. The proin-
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oxide synthase (NOS2), allowing the macrophage to kill intracellularly replicating Mtb.
However, Mtb has evolved various strategies to be able to survive in the hostile environ-
ment of the host cells, one of them is phagosome maturation arrest. Mtb derived lipid
mannose-capped lipoarabinomannan (ManLAM) interferes with Ca fluxes, thereby suppress-
ing hVPS34, necessary for PI3P production [138]. Mtb also secretes a lipid phosphatase,
SapM, that can dephosphorylate PI3P, therefore blocking phagosome-late endosome fusion
[139]. Mtb may also inhibit, subvert or modulate antigen presentation by MHC class I, class
II and CD1 molecules [10]. For example, Mtb disrupts MHC class II presentation in several
ways. The prolonged binding of Mtb 19 kDa lipoprotein LpqH to TLR2 leads to increased
expression of several transcription factors which repress transcription of the MHC class II
transcriptional transactivator (CIITA), resulting in decreased MHC II expression on Mtb
infected cells [144, 10]. Mycobacterial infection also induces the production of interleukin
(IL)-10 suppressing cathepsin S, the most important protease capable of mediating the late
steps of Ii cleavage needed to generate MHC class II molecules that can be efficiently loaded
with peptide antigens [10]. Due to the nature of its cell wall, Mtb is also able to resist
oxidative radicals, such as nitrogen and oxygen species, intended to kill the pathogen within
the macrophages.
1.3.4 Mtb and nutrient acquisition
Host defence against pathogens also consists of restricting the availability of nutrients to the
pathogen as the pathogen may exploit the host sources for its survival. Mtb exploits the
host to acquire nutrients. For instance, Mtb possesses proteins that are involved in uptake of
nutrients such as phosphate, sulfate and some amino acids. Therefore host defence against
pathogens consist also of restricting the availability of nutrients to the pathogen as illustrated
by iron or tryptophan.
Iron is an indispensable nutrient for almost all organisms [117]. Iron is essential for growth
of Mtb [110]. In the host, it is required for host metabolism and other important host
functions, such as production of reactive oxygen intermediates (ROI) and reactive nitrogen
intermediates (RNI) [117]. Iron circulates in the blood stream in the form of a transferrin-
iron complex. Macrophages have the transferrin receptor (TfR) which binds the transferrin
(Tf)-iron complex. The Tf/TfR complex is then internalised via the classical endocytic
pathway into an early endosomal compartment. Once inside the cell, the iron is released
from Tf and used by the cell. Unused iron is stored bound to ferritin, the iron storage
molecules. Since Mtb blocks phagosome maturation at an early endosomal stage, it can
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reduce intracellular iron by downregulating expression of the TfR in order to reduce bacterial
growth [117]. To maintain their intracellular iron supply, Mtb produce small molecules called
siderophores which are secreted into the extracellular space, bind iron and are reinternalised
via specific cell surface receptors [34].
Mtb may acquire amino acids from the host and synthesize its own amino acids when they are
not available from the host. For instance, Mtb is able to import tryptophan from the host,
and tryptophan auxotroph are unable to survive single-amino-acid starvation [97]. Upon
infection, the host limits tryptophan availability inside the macrophages. This mechanism
is activated by IFN-γ, which induces expression of indoleamine 2,3-dioxygenase (IDO) to
catabolize transformation of L-tryptophan to N-formylkynurenine, leading to tryptophan
depletion inside the cell [117]. Restriction from host-cell sources activates the endogenous
tryptophan synthesis of the microbe [117].
The outcome of Mtb infection thus depends on the interplay between the host and pathogen.
The pathogen proteins interacting with human host might be essential for survival of the
pathogen inside the host by acquiring nutrients or interfering with the host defence system.
Therefore, knowledge of the set of interacting human and mycobacterial proteins may help
us understand the mechanisms of infection and aid in the design of new drugs. Before
attempting to find the host-pathogen protein interactions, the protein interaction networks
of both the host and the pathogen have to be constructed. The interactions occurring within
the same species are known as intra-species interactions, whereas those occurring between
different species are called inter-species interactions.
1.4 Protein-protein interactions
Proteins rarely work in isolation, but rather interact with other proteins to carry out their
functions. The term interaction does not refer only to physical contact between proteins in
a cell but refers to functional interactions. Functional interactions or relationships between
proteins involve characteristics which allow particular proteins to carry out their functions
together with related proteins without necessarily having physical contact. The set of pro-
tein interactions in an organism forms the protein-protein interaction (PPI) network. In this
work, we are using all functional interactions for the host and pathogen PPI networks. There-
fore, the networks include interactions without direct physical contact. PPIs are detected
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1.4.1 Experimental methods for PPIs detection
There are many experimental methods for detecting PPIs. These techniques facilitate a
large-scale determination of PPIs. However, these data are prone to high false positive and
false negative interaction rates [140]. Co-immunoprecipitations, surface plasmon resonance,
nuclear magnetic resonance, X-ray crystallography, label transfer, FRET and far western
blot are small-scale experiments for detecting PPIs. Although producing more accurate
results compared to high-throughput methods, small-scale experiments are limited in terms
of coverage of the interactome. Some of the experimental methods are described below.
• Yeast two-hybrid (Y2H) [127]
The Y2H method is based on transcriptional activation. DNA transcription requires a
protein called a transcriptional activator (TA), which contains a DNA-binding domain,
for binding to DNA, and an activation domain, for activating transcription of DNA.
In order to initiate transcription, the TA binds to the “promoter”, a region situated
upstream from the gene, via its binding-domain. The activation domain of the TA will
then activate transcription. Therefore, transcription of a gene will fail if either of these
domains is absent from the TA. In the two-hybrid assay, the protein of interest, the
“bait”, is fused to a DNA-binding domain by inserting the segment of DNA encoding
the bait into a plasmid. Similarly, proteins that bind to the bait, the “fish”, are fused
to a transcription activation domain. Any protein that binds to the bait will activate
the transcription of a reporter gene, which is a gene whose protein product can be
easily detected and measured.
• Mass spectrometry (MS) [15]
The MS method is based on the production of ionized peptides which can be detected
based on their mass-to-charge ratios, allowing the identification of the original protein
or their polypeptide sequences through their masses. MS is often coupled to affinity
purification techniques to identify protein-protein interactions. Here we describe the
general strategy used to characterize protein complex composition using MS.
A protein of interest is tagged with a specific tag. Crude sample containing the tagged
protein, along with its binding partners, is then incubated with a support where a
ligand of the tag in the protein of interest is chemically immobilized. The target
protein in the sample will bind to the immobilized ligand. Other sample components
are washed away from the support. The target protein and its interactors are then
dissociated and recovered from the immobilized ligand. Eluted protein complexes are
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dimensional separation methods. Isolated proteins are proteolytically digested and
analyzed by MS. The isolated proteins are converted into ions by using Electrospray
Ionization and Matrix Assisted Laser Desorption Ionization (MALDI). These ions are
separated according to their mass (m) -to-charge (z) ratios (m/z). The separated
ions are detected and this signal is sent to a data system where the m/z ratios are
stored together with their relative abundance for presentation in the format of a m/z
spectrum.
• DNA and protein microarrays [22]
The technique using DNA microarrays is based on the assumption that interacting
proteins are more likely to have their genes co-expressed. Microarrays measure the
expression levels of genes by measuring the kinds and amounts of messenger RNA
(mRNA) in a cell. DNA microarrays are flat surfaces, typically glass microscope slides,
which contain 10,000 to 100,000 spots. Each spot contains multiple single-stranded
DNA called the probe and it represents one gene. An mRNA-DNA bond is formed
when an mRNA molecule, which is complementary to the probe, hybridizes to that
probe. The mRNA molecules, also called targets, are labelled with a fluorescent dye
before hybridization. When the targets are ex osed to the microarray, the level of
fluorescence of the dye will represent the amount of hybridization that has taken place.
While DNA microarrays don’t measure physical bind of proteins like the methods
described above, some protein microarrays, for example antibody arrays, are able to
detect physical binding.
Experimental interaction detection is generally expensive, time-consuming and has low ac-
curacy [23]. Computational approaches have therefore been proposed to deal with these
problems.
1.4.2 Computational methods for PPIs prediction
Computational methods are divided into two major groups: those that can detect func-
tional links and those that predict physical protein-protein interactions. Methods such as
gene neighbour, gene fusion and phylogenetic profile predict functional links while physical
interaction is detected by domain-domain interactions or interologs.
• Gene neighbourhood or co-localization
This method is based on the notion that functionally associated genes will stay close
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generally transcribed as a single unit or operon. In eukaryotes, genes that are observed
in close proximity several times across many genomes are predicted to functionally
interact [122]. In fact, genes involved in the same biological process or pathway are
frequently situated in close genomic proximity.
• Phylogenetic profile
The co-occurence of pairs of genes across multiple genomes suggest that these genes are
functionally associated. In this method, a gene is described by its phylogenetic profile
which is a record of the absence or presence of the proteins in a given set of genomes.
Proteins that have similar phylogenetic profiles are predicted to interact [100].
• Gene fusion
There is a gene fusion event when two separate parent genes are physically fused into
a single multifunctional gene. Gene fusion can be viewed as the extreme form of
gene co-localization because interacting genes are not only close to each other on the
genome, but are physically joined in one single gene. In this approach, one looks for
homologous protein sequences to a reference protein (fused protein), but not to each
other and which align to different regions of the reference protein. This suggests that
the two initial proteins are functionally linked [45].
• Text mining
Text mining methods are used to infer protein-protein interactions from the large
amount of biomedical literature. Text mining techniques to derive PPIs are mainly
divided into two groups, one using statistical method and the other one using compu-
tational linguistic method. Statistical methods infer interactions between proteins by
calculating their co-occurrence frequencies. More precisely, the higher the frequencies
of two proteins appearing in the same sentences, paragraphs or articles, the more likely
these two proteins interact. Computational linguistic methods analyse sentence struc-
tures by defining grammars to define sentence structures and using parsers to extract
syntactic information and internal dependencies within individual sentences [17].
1.5 Host-pathogen interactions
The experimental methods for detecting intra-species protein interactions can also be ap-
plied to prediction of inter-species interactions. In this section, we describe some of the
computational methods that have been used for predicting host-pathogen interactions and
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1.5.1 Computational methods for predicting host-pathogen pro-
tein interactions
There are several methods for predicting inter-species protein interactions, most of which
have been applied to Plasmodium falciparum and HIV protein interaction with human. We
briefly introduce some of these methods here.
Dyer et al. [43] predicted human-Plasmodium falciparum protein interactions by integrating
known intra-species PPIs with protein-domain profiles. They first identified the functional
domains in each interacting protein of a set of intra-species PPIs. Then, using Bayesian
statistics, they assess the probability that two proteins with a pair of domains will interact,
for every pair of functional domains. They predicted 516 PPIs between the two organisms
using this method.
Lee et al. [77] used interologs to predict human-Plasmodium falciparum protein interactions.
Interologs are conserved protein interactions between organisms. In this method, two host-
pathogen proteins are predicted to interact if they have interacting orthologs in another
organism. They inferred more than 3,000 human-Plasmodium falciparum PPIs. Since not
all the interactions are likely to take place, they used gene ontology annotations to filter the
interactions, leading to 918 host-pathogen interactions.
Interaction prediction between HIV and human proteins has also been performed. Tastan et
al. [131] used a Random Forest classifier (RF) to classify protein pairs as either “interacting”
or “not-interacting” based on biological information sources. Evans et al. [46] predicted HIV-
human protein interactions using virus and host sequence motifs. Doolittle and Gomez [39]
predicted interactions between HIV and human proteins based on structural similarity of HIV
proteins to human proteins having known interactions. In the context of Mtb-human protein
interactions, Krishnadev et al. [72] applied a homology-based method to predict protein
interactions. Another study by Davis et al. [37] used comparative modelling to predict
host-pathogen PPIs with ten pathogens, including Mycobacterium tuberculosis. From host
and pathogen protein pairs sharing similarity to protein complexes with known structures,
3D structural models of putative complexes were built.
1.5.2 Databases of host-pathogen interactions
Although many databases store intra-species interactions, there is a limited number of
databases designed specifically for inter-species interactions. Moreover, they are limited
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• Host-Pathogen Interaction database (http://agbase.msstate.edu/hpi/main.
html) [75]
Host-Pathogen Interaction database (HPIDB) integrates experimental PPIs from var-
ious public databases and also allows the retrieval of homologous host/pathogen se-
quences. HPIDB contains interactions between 49 hosts and 319 pathogens. Host
species include human, mouse, mouse-ear cress, rat, bovine and chicken. Pathogenic
species include bacteria, virus, protist and fungi.
• Pathosystems Resource Integration Center (http://www.patricbrc.org/)
Pathosystems Resource Integration Center or PATRIC is an information system in-
tegrating a comprehensive bacterial genomics database with computational tools for
bioinformatics analysis. PATRIC contains experimentally confirmed protein interac-
tions between human and bacterial proteins.
• Pathogen-Host Interaction Data Integration and Analysis System (http:
//www.phidias.us)
Pathogen-Host Interaction Data Integration and Analysis System (PHIDIAS) allows
the search, comparison, and analysis of integrated genome sequences, conserved do-
mains, and gene expression data related to pathogen-host interactions [145]. It includes
42 pathogens, most of them in the category A, B and C priority pathogens identified by
the National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for
Disease Control and Prevention (CDC) in the USA. The pathogen species also include
the human immunodeficiency virus (HIV) and Plasmodium falciparum, both of them
considered as high priority with regard to public health.
• Virus–Host Network (http://pbildb1.univ-lyon1.fr/virhostnet/)
Virus–Host Network (VirHostNet) database is specialized in virus–virus, virus–host
and host–host interaction networks [93].
To our knowledge, there are no databases that provide a comprehensive set of human-
Mycobacterium tuberculosis protein interactions.
1.6 Network measures and network topology
Biological networks are modelled using graphs, which are a collection of nodes and edges
joining two nodes. Graphs are mathematical concepts that give insight into the organisation
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section, we first present some network measures that are used to analyse networks and
assess their characteristics, thereafter we present the network topologies.
1.6.1 Network measures
There are several network measures used to compare and analyse complex networks.
Degree (or connectivity) of a node
The degree k of a node is the simplest measure characterizing a node and is just the
number of links a node has.
Mean path length
The shortest path length between two nodes is the minimum number of edges needed
to connect one node to the other. The mean path length is the average path length of
the shortest paths between all pairs of nodes in the network. This measure reflects the
ability of two nodes to communicate with each other.
Degree distribution





where N(k) is the number of nodes with degree k, k = 1, 2, . . . and N is the total
number of nodes in the network. Networks have different topologies according to their
degree distribution.
1.6.2 Network topologies
The form of the degree distribution P (k) provides an insight into the network topology,
which enables us to have a broad view of the network’s characteristics. Here we give two
network topologies that are relevant to the understanding of biological networks.
Random network
Random networks have a degree distribution P (k) essentially following a Poisson distri-
bution. This type of network is homogeneous, meaning that most nodes have roughly
the same number of links.
Scale-free network
Scale-free networks have a degree distribution following a power law. Scale-free net-
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many nodes with few interactions. Several studies have shown that biological networks
are scale-free. For instance, investigation of the protein networks of S. cerevisae [147],
E. coli, D. melanogaster, C. elegans and H. pylori showed that they all are scale-free
[55].
Analysis of the topological properties of networks is important for drug discovery. In fact,
biological networks, which are scale-free, are very resistant to random removal of nodes but
rapidly disintegrate when facing targeted removal of the highly connected nodes or hubs,
therefore diminishing the ability of the nodes to communicate with other nodes. Jeong et al.
[3] showed that hubs tend to be essential proteins (proteins that, when knocked out, render
the cell unviable).
1.7 Problem statement and overview of thesis
Protein interactions between the host and Mtb are essential for Mtb survival in the host by
modulating the host response to bacterial infection or by acquiring nutrients it requires for its
growth. Therefore, the identification of the protein interactions that Mtb uses to invade the
host can contribute to the process of identifying potential targets for designing new drugs.
Unfortunately, experimental studies of host pathogen interactions are very scarce, hence
we have to rely on computational methods to predict host-pathogen interactions. Host-
pathogen interactions have been predicted using protein-domain profiles, sequence motifs,
Random Forest classifier, comparative modelling and interologs. The aim of this project is
to predict human-Mtb protein-protein interactions using the interologs method with intra-
species and inter-species interactions as data for interaction prediction and overlay them
onto a human and Mtb protein interaction network.
Chapter 2 describes the construction of both the human and Mtb PPIs and the prediction of
host-pathogen interactions. In Chapter 3, we analyse features of the predicted interactions
such as their subcellular locations, pathways and GO biological processes. Figure 1.1 provides
a flowchart of the procedure followed in Chapters 2 and 3 to achieve the aims of the project.
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2.1 Human protein-protein interaction network
In 2000, Uetz et al. undertook the first large-scale protein interaction study, which was done
in yeast [133], and studies have also been done in the fly [53] and the worm [79]. For the
human interactome, attempts to map the protein interaction network have also been made
by different groups: Bader et al. [9], Peri et al. [101], and Ramani et al. [109] built maps
from literature searches, Lehner and Fraser [78], Brown and Jurisica [21], and Persico et al.
[102] used orthologs, and Rual et al. [114] and Stelzl et al. (2005) [125] generated their map
based on large-scale yeast two-hybrid data.
The human interactome is estimated to contain approximately 20,000-25,000 proteins and
roughly 154,000-369,000 interactions. The large variation in the number of interactions is
largely due to the methods for predicting these interactions.
Major databases that store human protein-protein interactions are described below.
• BIND or Biomolecular Interaction Network Database (http://www.bind.ca)
BIND consists of biomolecular interaction, reaction, complex and pathway information.
Interactions are obtained from curation of published experimental research. BIND con-
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• BioGRID or Biological General Repository for Interaction Datasets (http://thebiogrid.
org)
BioGRID is a database of protein and genetic interactions from major model organism
species. Data in BioGRID come from curation of large- and small-scale experimental
data found in primary literature. The current release of BioGRID (3.1.93) contains
375,704 unique interactions and 44,908 proteins. 40 species are represented in Bi-
oGRID, including Arabidopsis thaliana, Caenorhabditis elegans, Drosophila melanogaster,
Escherichia coli, Hepatitus C Virus, Human Immunodeficiency Virus 1 and 2, Mus
musculus, Oryza sativa, Plasmodium falciparum 3D7 and Saccharomyces cerevisiae.
There are 83,592 unique interactions and 15,549 proteins for human.
• DIP or Database of Interacting Proteins (http://dip.doe-mbi.ucla.edu)
DIP collect experimentally determined protein-protein interactions that are curated,
both manually by expert curators and also automatically using computational ap-
proaches. DIP currently contains 25,023 proteins, 74,355 interactions and 517 or-
ganisms. Some selected organisms are Arabidopsis thaliana, Caenorhabditis elegans,
Drosophila melanogaster, Escherichia coli, Mus musculus, Bos taurus, Rattus norvegi-
cus, Helicobacter pylori and Saccharomyces cerevisiae. DIP now contains 3,386 human
proteins and 1,425 interactions.
• HPRD or Human Protein Reference Database (http://www.hprd.org)
HPRD is dedicated to human proteins. Apart from PPIs, it also contains information
about post-translational modifications, subcellular localization, protein domain archi-
tecture, tissue expression and association with human diseases. HPRD currently has
30,047 protein entries and 41,327 protein interactions.
• IntAct (http://www.ebi.ac.uk/intact)
Data in IntAct are from the literature or from direct data depositions by expert cu-
rators.IntAct contains 62,450 proteins and 204,629 interactions and complexes from
more than 275 organisms, though they are focusing on model organisms such as H.
sapiens, M. musculus, C. elegans, D. melanogaster, A. thaliana and E. coli. 89,519
human interactions and more than 17,500 human proteins are now included in IntAct.
• MINT or Molecular INteraction Database (http://mint.bio.uniroma2.it/mint/
Welcome.do)
MINT stores interactions between biological molecules and focuses on experimentally
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241,373 interactions from more than 300 organisms. Among them, 8,639 proteins and
26,761 interactions are for human.
2.1.1 Human network generation
We used three datasets to construct our human interaction network. The first one is the
human protein interaction network used by Bossi and Lehner [18], the second and the third
were downloaded from REACTOME and STRING, respectively.
Bossi and Lehner integrated data from 21 sources to build their human protein network.
They only included interactions supported by at least one piece of direct experimental evi-
dence demonstrating physical association between two human proteins. In addition to the
direct evidence, some interactions also have supporting evidence. Bossi and Lehner used
21 sources for the data divided into 26 categories. In order to quantify the interactions,
each interaction has been assigned a score which depends on the reliability of the source,
experimentally verified interactions are given a higher score. The interaction categories and
their corresponding scores are shown in Table 2.1.
REACTOME is an expert-curated and highly reliable database of human biological path-
ways and reactions. The interactions from REACTOME were given a score of 0.95 like the
REACTOME source in the Bossi and Lehner data. The REACTOME data used here is
more recent data than that used by Bossi and Lehner.
STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) is a database for the
exploration and analysis of protein-protein interactions. Data contained in the STRING
database are derived from experimental data, as well as from public literature collections
and computational prediction methods based on domain fusion, phylogenetic profiling, ho-
mology and gene neighbourhood concepts. In STRING, a confidence score is assigned to
each identified protein-protein association, derived by benchmarking the performance of the
predictions against a common reference set. To provide a unified view of the data, STRING
uses a scoring scheme that integrates all the different methods to produce a final “com-
bined score” between any pairwise predicted protein. Assuming that all the methods are





where si is the score from the method i and n is the number of methods. An interaction
between two proteins has a higher score when it is supported by several types of evidence,
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Source Description Score
ATAXIA Literature, stringent two-hybrid 0.85
CORUM Experimentally verified mammalian protein complexes 0.9
HPRD Manual curation of PPIs from literature, experiments in vivo, in
vitro and Y2H
0.85
INTACT Literature curation or direct submissions 0.85
MDC Y2H plus verification 0.85
OPHID Data integration, known and predicted PPIs, orthology 0.75
UNILEVER Y2H, mass spectrometry, literature 0.85
INTNET PPI predictions from data integration 0.75
BIOVERSE Data integration 0.75
BIOGRID Literature curated interactions 0.85
REACTOME Curated interactions 0.95
BIND Literature curated interactions 0.85
CCSB-curated Stringent Y2H 0.78
DIP Experimentally determined PPIs 0.85
MIPS Literature curated experimental interactions 0.85
EWING Affinity purification, mass spectrometry + verification 0.85
JERONIMO Experimental protein complexes 0.9




Phenotype similarity Share phenotype 0.65
Genetic Genetic interaction 0.6
Co-expression Co-expression 0.65
Domain-domain interaction Domain-domain interaction 0.65
Shared GO annotation Share GO process 0.5
Interolog Inferred from orthologs 0.7
Share upstream motif Shared upstream region 0.5
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All the three networks above have different IDs for the genes, so we converted all the IDs
to UniProt IDs in order to unify the data. We used the database identifier mapping (ID
Mapping) tool in UniProt for this purpose. This tool maps a lists of identifiers from an
external database to UniProtKB, taking as input database identifiers. In our case, we up-
loaded the files containing the nodes of our three networks. As the source database, we
selected Ensembl and Ensembl protein for the Bossi and Lehner and STRING networks,
respectively. The REACTOME network already had UniProt IDs. The target database
was set to UniProtKB AC. We then downloaded tab-separated tables mapping the source
database identifiers to UniProt identifier. After converting the IDs of the two networks to
UniProt IDs, we combined the three individual networks to form a single network, where
self-interacting proteins were removed. Each interaction of this network was represented by
the interacting proteins, along with the various scores from the individual data, including the
26 scores from the Bossi and Lehner network, the REACTOME score and the final STRING
score. The same formula as in Equation (2.1) was used to compute the final score S for
each interaction, but now si is the score from each different source and n is the number of
sources. Therefore, an interaction predicted by more than one database has a higher score,
expressing an increased reliability. We obtained a human network consisting of 18,343 pro-
teins and 1,339,048 interactions. To increase the reliability of the network, only interactions
that have a final score S ≥ 0.65 were used to build the network. A cut-off score of 0.65 was
chosen because the interactions in the Bossi and Lehner network which have a score greater
or equal to 0.65 are considered to be reliable. 1,004,978 interactions and 1,795 proteins were
filtered out during this process. Ultimately, we obtained a human network of 16,548 proteins
and 334,070 interactions.
2.1.2 Topological properties of the human PPI network
In order to analyse and manipulate the netwoks, we used NetworkX which is a library for the
Python scripting language. NetworkX allows the creation, manipulation, and study of the
structure and dynamics of complex networks (http://networkx.lanl.gov/). To study the
topological properties of our network, we created a tab-delimited file of the graph, where a
line is an interaction between two proteins represented by their UniProt accession. We then
computed the characteristics of the network and results are shown in Table 2.2.
Proteins in the human network possess an average of 40 neighbours. As seen in Figure 2.1,
the node degree distribution of the human network shows a scale-free network topological
property, where few proteins are highly connected and most proteins have a low number of
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Number of proteins 16,548
Number of interactions 334,070
Average degree 40.3759
Number of connected components 52
Percentage of nodes in the largest connected component 99.35%
Average shortest path length 3.507646
Table 2.2: Characteristics of the human network
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Human network degree distribution
Figure 2.1: Human network degree distribution
size, showing that our human network has a “small world property” – a path of a few links
can connect any two nodes in the network.
The node degree distribution of the human network shows an outlier. These are 257 proteins
of degree 284. These proteins are olfactory receptors except Q92620, which is a pre-mRNA-
splicing factor ATP-dependent RNA helicase PRP16. The olfactory receptor proteins form
a clique (every two nodes connected by an edge) and are connected to the same 29 proteins.
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2.2 Mtb protein-protein interaction network and prop-
erties
Yeast-two hybrid (Y2H) systems have been used to investigate protein-protein interaction
networks in a number of models including human, C. elegans and D. melanogaster. However,
very few studies have been done on bacterial species. For Mtb in particular, Wang et al. [142]
constructed a global Mtb network using yeast-two hybrid. Their network contains 8,042 in-
teractions between 2,907 proteins, representing about 74.1 % of functional proteins encoded
by the entire genome. The STRING database (described in section 2.1.1) contains PPI net-
works for various Mtb strains namely Mycobacterium tuberculosis CDC1551, Mycobacterium
tuberculosis H37Rv, Mycobacterium tuberculosis F11, Mycobacterium tuberculosis H37Ra,
and Mycobacterium tuberculosis KZN 1435.
2.2.1 Mtb network generation
The Mycobacterium tuberculosis genome contains roughly 4,000 protein coding genes. The
protein interaction network of Mtb strain CDC1551 was previously generated through a
combination of data extracted from the STRING database and from gene expression and
sequence data [84]. From STRING, the following prediction methods were used: neigh-
bourhood, gene fusion, co-occurence, experiments, databases and text mining. Interactions
from gene expression data were derived from multiple microarray datasets and use a random
partial least squares approach for scoring interactions [87]. Interactions from sequence data
comprise sequence similarity and domain data. The similarity score used here comes from
[85] and is defined by:
R(s1, s2) =
S(s1, s2) + S(s2, s1)
2 max{S(s1, s1), S(s2, s2)}
where S(si, sj) is the bit score alignment of homologous sequences si and sj.
The relationship score between pairwise proteins i and j sharing common InterPro hits is
given by:
rij(δ) = (1−H2(δ))/bit
where H2(δ) is the binary entropy function measuring the uncertainty related to the number
n of common InterPro hits in the set of InterPro hits. This entropy is given by
H2(δ) = −δ log2(δ)− (1− δ) log2(1− δ)
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where σ denotes the standard deviation and α ≥ 0.05, the calibration control parameter,
strengthening the impact of the confidence-level for the data under consideration [85].
The same scoring method used for the human network was used to unify the Mtb data.
The interactions in STRING are divided into a confidence range: low confidence if the
score < 0.3, medium confidence if 0.3 ≤ score ≤ 0.7 and high confidence if the score > 0.7.
A cut-off of 0.5 was set to select the interactions that are in the final network used for the
analysis so that we would not pick interactions with a score too low but still have medium
confidence interactions. In the end, we obtained 4,070 proteins joined by 38,049 edges.
2.2.2 Topological properties of the Mtb network
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Mtb network degree distribution
Figure 2.2: Degree distribution of the Mtb network
The characteristics of the final Mtb network are shown in Table 2.3. Our Mtb network
has 68 connected components, where 95.97% of the nodes belong to the largest connected
component. The average degree of a node in the Mtb network is 18.69. Like the human
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Number of proteins 4,070
Number of interactions 38,049
Average degree 18.693
Number of connected components 68
Percentage of nodes in the largest connected component 95.97%
Average shortest path length 4.241
Table 2.3: Characteristics of the Mtb network
shortest path length of 4.24 and the degree distribution also shows a scale-free network
(Figure 2.2).
2.3 Inter-species host-pathogen interaction prediction
2.3.1 Known host-pathogen interactions
Known human-Mtb protein interactions are not stored in databases as is the case for many
human-virus protein interactions. Therefore, manual curation of existing literature had to
be done in order to gather as many host-pathogen protein interactions as possible. Through
literature mining, we were able to retrieve 47 inter-species interactions between Mtb and
human where both interacting proteins were present in the networks we built. A list of these
known interactions is provided in Table 2.4.
The known human-Mtb protein interactions are mostly those involved in the recognition of
the pathogen by the host. Specific host receptors recognize specific Mtb components, for
example, the toll-like receptors (TLRs) recognize various bacterial lipoproteins (lprA [99],
lpqH [24], lprG [52]) whereas the human pulmonary surfactant protein A (PSP-A) binds to




Mtb protein name Human pro-
tein UniProt
Acc
Human protein name Reference
P0A5Q4 Immunogenic protein
MPT64
P25685 DnaJ homolog subfamily
B member 1
[32]
P0A5J0 Lipoprotein lpqH O60603 Toll-like receptor 2 [24]
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P0A5B9 Chaperone protein DnaK O00206 Toll-like receptor 4 [24]
P0A5B9 Chaperone protein DnaK O60603 Toll-like receptor 2 [24]
P0A4V2 Antigen 85-A P02751 Fibronectin [98]
P0C5B9 Antigen 85-B P02751 Fibronectin [98]
P0A4V4 Antigen 85-C P02751 Fibronectin [98]
Q7D8M9 PPE family protein,
PPE18




O60603 Toll-like receptor 2 [14]
Q11049 Putative lipoprotein lprA O60603 Toll-like receptor 2 [99]
P0A5I8 Lipoprotein lprG O60603 Toll-like receptor 2 [52]
P15712 Phosphate-binding pro-
tein pstS 1
O60603 Toll-like receptor 2 [67]
P15712 Phosphate-binding pro-
tein pstS 1
O00206 Toll-like receptor 4 [67]
Q50906 Alanine and proline-rich
secreted protein apa
Q9NNX6 CD209 antigen [104]
P0A5J0 Lipoprotein lpqH Q9NNX6 CD209 antigen [104]
P0A5B9 Chaperone protein DnaK P00747 Plasminogen [146]
P0A590 Glutamine synthetase 1 P00747 Plasminogen [146]




P0A5H3 Isocitrate lyase P00747 Plasminogen [146]







P0A4V2 Antigen 85-A P00747 Plasminogen [146]
P0C5B9 Antigen 85-B P00747 Plasminogen [146]
P0A4V4 Antigen 85-C P00747 Plasminogen [146]
P0A4V6 MPT51/MPB51 antigen P00747 Plasminogen [146]




P09621 10 kDa chaperonin P00747 Plasminogen [146]
P0A5B9 Chaperone protein DnaK Q9NNX6 CD209 antigen [30]
P0A518 60 kDa chaperonin 1 Q9NNX6 CD209 antigen [30]
P0A5I8 Lipoprotein lprG Q9NNX6 CD209 antigen [30]
P0A5I8 Lipoprotein lprG Q9H2X3 C-type lectin domain fam-
ily 4 member M
[30]
P0A4V4 Antigen 85-C P05107 Integrin beta-2 [60]
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P0A5J0 Lipoprotein lpqH P08571 Monocyte differentiation
antigen CD14
[40]
Q11049 Putative lipoprotein lprA Q15399 Toll-like receptor 1 [40]
Q11049 Putative lipoprotein lprA Q9Y2C9 Toll-like receptor 6 [40]
Q11049 Putative lipoprotein lprA P08571 Monocyte differentiation
antigen CD14
[40]
P0A5I8 Lipoprotein lprG Q15399 Toll-like receptor 1 [40]





Q15399 Toll-like receptor 1 [40]










P0A564 6 kDa early secretory anti-
genic target
O00560 Syntenin-1 [120]
Table 2.4: Known host-pathogen interactions from the literature
2.3.2 Host-pathogen interaction prediction using interologs
The term “interolog” was first introduced by Walhout et al. [141]. Interologs are conserved
interactions between a pair of proteins which have interacting orthologs in another organism.
More precisely, the interaction X/Y in one species is referred to as interologs of X ′/Y ′ in
another species if X ′ and Y ′ are orthologs of X and Y , respectively.
The interolog method has mostly been used to infer intra-species interactions in higher or-
der organisms such as Homo sapiens and has also been applied to inter-species interaction
prediction. For example, Lee et al. used interologs to predict host-pathogen interactions
between Homo sapiens and Plasmodium falciparum [77]. An interaction between a P. fal-
ciparum protein Pa and a human protein Hb is inferred if the ortholog Sa of Pa and the
ortholog Sb of Hb in species S interact. We used the same principle to infer interactions
between Homo sapiens and Mtb. The human and Mtb orthologs were downloaded from
INTEGR8 (http://www.ebi.ac.uk/integr8), and the known interactions were extracted
from the DIP database. To infer an interaction between a human protein and a Mtb protein,
we first took a human protein Ha and determined whether it had an ortholog Sa. If this
was the case, then we looked for the interacting partner Sb of Sa in the DIP database. If an
interacting partner Sb was found, we checked whether it had an ortholog Mb in Mtb. When
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Figure 2.3: Steps for inferring inter-species interactions using the interologs method. Dotted
lines represent orthologs, the solid line represents intra-species interaction and the dashed
line represents inferred inter-species interaction.
A total of 483 host-pathogen interactions between 175 human and 192 Mtb proteins were
found using the interolog method described above. 10 reference species were used to infer the
interologs. Table 2.5 lists the reference species along with the resulting number of interologs.
The original species are phylogenetically close enough to either human or Mtb to assume no
false positives and we assumed that orthologs should have conserved functions.
Original species Number of interactions
M. smegmatis 1
M. musculus 10





E. coli ATCC 27325 54
E. coli MG1655 260
R. norvegicus 6
Table 2.5: Original species and number of interactions for the interologs
The interactions were further investigated by filtering based on two criteria: connections to
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2.3.3 Filtering for “interolog-known” interactions
In order to analyse the interologs predicted, we first looked at the cases where both proteins
were neighbours of known interactions, referred to as “interolog-known” interactions. The
network definition of neighbourhood is used here, which is two proteins are neighbours if there
exists an edge connecting them in the network. Practically, to predict the “interolog-known”
interactions, we took all possible (interolog,known) pairs where interolog is an inter-
species interaction predicted by interologs and known is a known inter-species interaction.
If the human interolog protein is a neighbour of the human known protein and the Mtb
interolog protein is a neighbour of the Mtb known protein, then interolog is an “interolog-
known” interaction. Among the 483 host-pathogen interactions, 3 interactions fall into
the “interolog-known” category. We predicted that the human P07814 protein, which is
a bifunctional aminoacyl-tRNA synthetase, interacts with P0A5U4 (RecA, recombinase A)
from Mtb. The RecA protein is a recombinase functioning in recombinational DNA repair in
bacteria. These two proteins are the neighbours of the human protein P00747 (plasminogen)
and the mycobacterial protein P77899 (S-adenosylmethionine synthase), respectively. An
interaction between the human protein ATP synthase subunit beta, mitochondrial, P06576
and the Mtb protein P0A548, a chaperone protein DnaJ 1, was also predicted. This second
predicted interaction is the neighbour of three known interactions between one human protein
(P00747) and three Mtb proteins: P0A5B9 (chaperone protein DnaK), P0A558 (elongation
factor Tu) and P77899. The third interaction involves the human protein P27361, which is a
mitogen-activated protein kinase 3 (MAPK3), and the probable acetyl-CoA acyltransferase
fadA2 from Mtb. MAPK3 is an enzyme which is a member of a MAPK family. Induction
of the MAPK pathway is required for the expression of TNF-alpha, IL-10, and MCP-1 by
human monocytes during M. tuberculosis H37Rv infection [124]. The third interaction is
the neighbour of the interaction between the human protein O00206 (toll-like receptor 4)
and the Mtb protein P0A520 (60 kDa chaperonin 2). The “interolog-known” interactions
are listed in Table 2.6 and are visualised in Figure 2.4 together with the known interactions
of which they are the neighbours. Network visualisation was done using Cytoscape (http:
//www.cytoscape.org/), which is a popular bioinformatics package for biological network
visualization and data integration. To create a network in Cytoscape, we imported tab-
delimited text file of the network. One row in the file represented an edge and its edge
attribute. In our case, the edge attributes are the type of the interactions, such as inter-
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Figure 2.4: Interactions predicted by interologs which are neighbour of known interactions.
Pink nodes are human proteins and pink edges are human PPIs. Blue nodes are Mtb proteins
are blue edges are Mtb PPIs. Red edges are known human-Mtb interactions and green edges
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Human UniProt ID Human protein name Mtb UniProt ID Mtb protein name
P07814 EPRS, bifunctional aminoacyl-
tRNA synthetase
P0A5U4 RecA, recombinase A
P06576 ATP5B, ATP synthase subunit
beta, mitochondrial
P0A548 DnaJ1, chaperone protein DnaJ
1
P27361 MAPK3, mitogen-activated pro-
tein kinase 3
O86361 fadA2, probable acetyl-CoA
acyltransferase FADA2
Table 2.6: The “interolog-known” interactions
2.3.4 Filtering for “interolog-array” interactions
We also looked at the interologs where both of the proteins are differentially expressed in
microarray data, which we shall refer to as “interolog-array” interactions.
The outcome of an infection depends on how the host responds to the pathogen and how
the pathogen evades the immune system. Investigation of the entire transcriptome of a
cell during infection may provide a hint about the host-pathogen cross-talk. This is easily
feasible using microarray technology which allows the simultaneous analysis of expression
of thousand of genes. Therefore, this method has been widely used to study the interplay
between the host and the pathogen. Unfortunately, the microarray data gives us only set
of genes that might interact as they are expressed under the appropriate conditions but do
not tell us explicitly which gene interacts with which other gene. That is why we combined
the interactions predicted by interologs with the microarray data: the interologs give the
interactions and the microarray data ensure that the interactions could occur.
For human-Mtb interactions, a number of groups have studied the global gene expression
profile of Mtb-infected human macrophages (Mϕs) and dendritic cells (DCs) [31, 108], and
some analysed the mycobacterial transcriptome in human Mϕs [28] or in human lung tissue
samples [106]. These studies have been conducted in either the host or the pathogen. We
used microarray data from Tailleux et al. for our analysis [128]. They used microarray
technology to decipher transcriptional changes upon infection both in Mtb and in Mϕs and
DCs derived from the same donors [128] over a time-course experiment. Here, we describe
briefly the procedures carried out and data analysis of the experiment, a detailed description
can be found in [128].
Cellular RNA was extracted from 9 individual donors at 4, 18 and 48 hours of infection
and at the time of infection (reference), producing a total of 72 samples. The samples were
labelled and hybridised to Human U133A oligonucleotide microarray chips with 22,283 probe
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They applied a filter based on Detection calls to filter out noisy data before selecting differen-
tially expressed genes: they first removed the probe sets called “Absent” over all conditions
and replicates; then they determined the 95th percentile of all the signals of the entire dataset
flagged with an absent call and used it as a threshold to remove all the remaining probe sets
whose expression values were always below the threshold in each sample. The remaining
probe sets were used for the analysis.
Differentially expressed genes were detected using the Limma Bioconductor library, which
is based on the fitting of a linear model to estimate the variability in the data. A threshold
p-value of 10−4 was used to select differentially expressed genes.
Mycobacterial RNA extracted from infected Mϕs and DCs from 3 healthy donors at 1, 4
and 18 hours after infection, and from two biological replicates of log phase in vitro growth
were hybridised in duplicate to a M. tuberculosis whole genome microarray. The hybridised
slides were then scanned sequentially and the data was analysed using the Limma software
package.
Raw human microarray data used in our analysis was provided by the authors of the ar-
ticle. We performed the analysis described above on the data to obtain the human genes
differentially expressed during Mtb infection. On the other hand, the list of Mtb genes dif-
ferentially expressed were downloaded from BµG@Sbase under the accession E-BUGS-58
(http://bugs.sgul.ac.uk/bugsbase).
To find the “interolog-array” interactions, we took the interologs and found those where both
human and Mtb proteins were differentially expressed in the above experiments. This led to
78 interactions between 35 human proteins and 47 Mtb proteins shown in Table 2.7.
Human Uniprot
Acc
Human protein name Mtb Uniprot
Acc
Mtb protein name
Q12965 MYO1E, myosin-Ie P67510 LeuS, leucyl-tRNA synthetase
Q9P2R7 SUCLA2, succinyl-CoA ligase
[ADP-forming] subunit beta, mi-
tochondrial
P96377 Eno, enolase
P71558 SucD, succinyl-CoA ligase [ADP-
forming] subunit alpha
O06249 GadB, glutamate decarboxylase
P63288 ClpB, chaperone protein ClpB
O06147 RpsA, 30S ribosomal protein S1
P0A658 Upp, uracil phosphoribosyltrans-
ferase
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P60891 PRPS1, ribose-phosphate py-
rophosphokinase 1
P0A5X6 RpsC, 30S ribosomal protein S3
P63973 LigA, DNA ligase
P07814 EPRS, bifunctional aminoacyl-
tRNA synthetase
P0A5U4 RecA, recombinase A
P53597 SUCLG1, succinyl-CoA ligase
[ADP/GDP-forming] subunit al-
pha, mitochondrial
P71559 SucC, Succinyl-CoA ligase
[ADP-forming] subunit beta
P25705 ATP5A1, ATP synthase subunit
alpha, mitochondrial
P63677 AtpD, ATP synthase subunit al-
pha
P0A620 TopA, DNA topoisomerase




P66875 MetB, Cystathionine gamma-
synthase
P0A528 ATP-dependent Clp protease
ATP-binding subunit ClpX
P63650 ScoB, probable succinyl-CoA:3-
ketoacid-coenzyme A transferase
subunit B
P0A644 RlmN, ribosomal RNA large sub-
unit methyltransferase N
P0A5U4 RecA, recombinase A





P0A5Y8 SecA1, protein translocase sub-
unit SecA1
O53832 PstB1, phosphate import ATP-
binding protein PstB 1
P47756 CAPZB, F-actin-capping protein
subunit beta




P66875 MetB, cystathionine gamma-
synthase
Q16740 CLPP, putative ATP-dependent
Clp protease proteolytic subunit,
mitochondrial
P0A520 GroL2, 60 kDa chaperonin 2
P0A528 ATP-dependent Clp protease
ATP-binding subunit ClpX
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O69664 GlpK, glycerol kinase
P00505 GOT2, aspartate aminotrans-
ferase, mitochondrial
P63937 MT0474, probable aldehyde de-
hydrogenase
P00558 PGK1, phosphoglycerate kinase
1
P96377 Eno, enolase
P96901 Lhr, ATP-dependent helicase,
putative
P49411 TUFM, elongation factor Tu, mi-
tochondrial
P66537 RpsB, 30S ribosomal protein S2
O69635 AcsA, acetyl-coenzyme A syn-
thetase
P0A520 GroL2, 60 kDa chaperonin 2
P95052 RplB, 50S ribosomal protein L2




P63650 ScoB, probable succinyl-CoA:3-
ketoacid-coenzyme A transferase
subunit B
P71715 DnaB, replicative DNA helicase




P63673 AtpA, ATP synthase subunit al-
pha
P28340 POLD1, DNA polymerase delta
catalytic subunit
P0A520 GroL2, 60 kDa chaperonin 2
P53582 METAP1, methionine
aminopeptidase 1
P67510 LeuS, leucyl-tRNA synthetase
P13929 ENO3, beta-enolase P71559 SucC, succinyl-CoA ligase [ADP-
forming] subunit beta
P65700 Pgk, phosphoglycerate kinase




O76031 CLPX, ATP-dependent Clp pro-




P63288 ClpB, chaperone protein ClpB
O53832 PstB1, phosphate import ATP-
binding
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P0A526 ClpP1, ATP-dependent Clp pro-
tease proteolytic subunit 1
P04406 GAPDH, glyceraldehyde-3-
phosphate dehydrogenase
P0A674 RpoC, DNA-directed RNA poly-
merase subunit beta’
O06134 Pyk, pyruvate kinase
P96901 Lhr, ATP-dependent helicase,
putative
P0A602 RpoD, RNA polymerase sigma
factor RpoD
Q13951 CBFB, core-binding factor sub-
unit beta
P0A558 Tuf, elongation factor Tu
P62244 RPS15A, 40S ribosomal protein
S15a
P64411 HtpG, chaperone protein htpG
P11908 PRPS2, ribose-phosphate py-
rophosphokinase 2
P95052 RplB, 50S ribosomal protein L2
P67510 LeuS, leucyl-tRNA synthetase
P0A520 GroL2, 60 kDa chaperonin 2
P06576 ATP5B, ATP synthase subunit
beta, mitochondrial
P63673 AtpA, ATP synthase subunit al-
pha
P63671 AtpG, ATP synthase gamma
chain
Q9H1K1 ISCU, iron-sulfur cluster assem-
bly enzyme ISCU, mitochondrial
P71558 SucD, succinyl-CoA ligase [ADP-
forming] subunit alpha
P10768 ESD, S-formylglutathione hydro-
lase
O69664 GlpK, glycerol kinase
P0A5Y8 SecA1, protein translocase sub-
unit SecA 1
P54819 AK2, adenylate kinase 2, mito-
chondrial
P63852 CtaD, probable cytochrome c ox-
idase subunit 1
Q99704 DOK1, docking protein 1 P0A544 SerA, D-3-phosphoglycerate de-
hydrogenase
P49588 AARS, alanyl-tRNA synthetase,
cytoplasmic
P0A636 GltX, glutamyl-tRNA syn-
thetase
P66016 PrfA, peptide chain release fac-
tor 1
P0A620 TopA, DNA topoisomerase 1
P30405 PPIF, peptidyl-prolyl cis-trans
isomerase F, mitochondrial
P96377 Eno, enolase
P11766 ADH5, alcohol dehydrogenase
class-3





P63977 DnaE1, DNA polymerase III
subunit alpha
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P0A644 RlmN, Ribosomal RNA large
subunit methyltransferase N
Table 2.7: The “interolog-array” interactions
2.3.4.1 Connections between predicted interactions
Figure 2.5 represents the known and “interolog-array” interactions in the networks. Due
to the size of the networks, especially the human network, only the first neighbours of the
proteins involved in the inter-species interactions are shown. Figure 2.5 shows that there are
3 small modules formed by known Mtb proteins interacting with human proteins. The first
module contains the Mtb protein PPE18 (Q7D8M9) which has 12 neighbour proteins. These
proteins are members of the PE/PPE family and one protein is EsxK (O05299), which is an
ESAT-6 like protein. The second module contains the proteins LpqH (P0A5J0) and Q50615.
The neighbours of these two proteins are members of the PE/PGRS family, which is the
largest class of the PE family. PE/PGRS proteins are characterized by a PE domain followed
by a PGRS domain, which is a polymorphic GC-rich repetitive sequences [13]. The third
module contains the alanine and proline-rich protein Apa (Q50906). This protein has as its
neighbours putative uncharacterised proteins, uncharacterised PPE family protein, alanine
and proline rich proteins and 3 proteins involved in the molybdenum transport system, which
link this module to the second module. The “interolog-array” interactions are represented in
Figure 2.6. This network has one large subnetwork containing 66 proteins. We compared the
size of this largest connected component to that of randomly generated networks having the
same characteristics as the “inte olog-array” interactions. A random network is generated by
randomly selecting 78 interactions among the 1,645 possible interactions between 35 human
proteins and 47 Mtb proteins. Repeating this process 5,000 times gives a largest component
of size 64, on average, and the probability of getting a largest connected component of size
66 is 0.1. The probability is given by counting how many times there are networks with
largest component of size 66 during the 5,000 iterations and by dividing this number by the
number of iterations.
Some of the human-Mtb protein-protein interactions are conserved interactions within one
organism (shaded oval in Figure 2.6), and they include interactions between ATP synthase
and Clp protease. Clp proteases are ATP-dependent proteases conserved among eubacteria
and most eukaryotes. They are responsible for degrading abnormal proteins [5]. Clp pro-
teases consist of two functional elements: a protease core (called ClpP and ClpQ) which can
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ATP synthase is a large membrane protein found in the plasma membrane of prokaryotes
and in mitochondrial membranes of eukaryotes [27]. In most cases, they are responsible for
ATP synthesis by creating a transmembrane proton gradient. They also work in the reverse
direction: they hydrolyze ATP to generate a transmembrane proton gradient. ATP syn-
thases consist of two structural domains: a membrane-bound FO portion and a soluble F1
portion. In E. coli, the F1-ATPase consists of 5 subunits α, β, γ, δ and ε and the FO-ATPase
consists of 3 subunits a, b and c [27]. In our interactions, ATP5A1 and ATP5B are the α and
β subunits of the human F1-ATPase, respectively, whereas atpA, atpD and atpG are the α,
β and γ subunits of the Mtb F1-ATP synthase, respectively.
2.3.5 Host-pathogen interaction prediction using inter-species in-
teractions
This method is a variant of the interologs method presented in 2.3.2. Instead of using intra-
species interactions to predict the interologs, we used experimentally verified interactions
between human and bacterial proteins. From the inter-species human-pathogen interactions,
if the pathogen has an ortholog in Mtb, we infer an interaction between human and Mtb
protein. The experimentally verified host-pathogen interactions were downloaded from two
databases dedicated to inter-species interactions, namely PATRIC and HPIDB (see 1.5.2).
We filtered host-pathogen interactions from HPIDB to only use human-bacterial protein
interactions. All the protein interactions from PATRIC were used since it contains only
human-bacterial protein interactions. The ortholog data for Mtb are from INTEGR8. Figure
2.7 shows how human-Mtb interaction is inferred.
We predicted 845 and 195 human-Mtb interactions from PATRIC and HPIDB data, respec-
tively. Combination of the two sets of interactions gave 1021 host-pathogen interactions
between 784 human proteins and 216 Mtb proteins. Among these interactions, there were
866 where both proteins belong to the constructed networks (644 human and 204 from Mtb).
These interactions were further investigated by considering only those differentially expressed
during infection.
2.3.6 Filtering for “database-array” interactions
We filtered the 866 host-pathogen interactions previously found by taking only the interac-
tions where both proteins are differentially expressed during infection. The same microarray
experiment as in 2.3.4 was used to find differentially expressed genes. By applying the fil-









































































































































































































































































Figure 2.7: Human-Mtb interactions from inter-species interactions. The solid line represents
experimentally verified host-pathogen interactions, the dotted line represents orthologs and
the dashed line represents the inferred human-Mtb interaction.
53 Mtb proteins. We shall refer to the filtered interactions as “database-array” interactions.
The initial interactions for the “database-array” interactions come from interactions between
human and three bacterial species, namely Bacillus anthracis, Francisella tularensis subsp.
tularensis and Yersinia pestis. This is due to the fact that a high-throughput yeast two-
hybrid assay was used to identify physical interactions between human proteins and proteins
from each of these three pathogens [44]. They therefore form most of the human-pathogen
interactions from PATRIC and HPIDB.
2.3.6.1 Connections between predicted interactions
The “database-array” interactions are visualized in Figure 2.8 and with the first neighbour of
the nodes in Figure 2.9. The network contains a large connected subnetwork of 61 proteins.
As for the “interolog-array” interactions, we randomly generated networks by selecting 109
interactions among the possible interactions between 85 human proteins and 53 Mtb proteins
and repeated the process 5,000 times. In this case, the average size of the largest connected
component is 19 and the probability of getting a largest connected component of size 61 is
0.01.
In the largest subnetwork of the “database-array” interactions, we observe several proteins
having 4 or more interactions. The human proteins NFKB1 and CD74 are connected to
10 and 5 Mtb proteins, respectively. Both of these proteins are known to play a role dur-
ing tuberculosis infection. NFKB1 (nuclear factor NF-kappa-B subunit p105) is part of the
NF-κB complex which controls the transcription of genes involved in the pro-inflammatory
response as well as genes involved in the antiapoptotic response. During early infection, Mtb
inhibits macrophage apoptosis by up-regulating the NF-κB signaling pathway, resulting in
the up-regulation of FLIP, an inhibitor of death receptor signaling [80]. CD74 or HLA class
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histocompatibility complex) class II proteins from the endoplasmic reticulum to the Golgi
complex. Mtb inhibits MHC class II antigen presentation which reduces the recognition of in-
fected macrophages by CD+4 T cells [59]. The Mtb proteins HemL (glutamate-1-semialdehyde
aminotransferase), RpoD (RNA polymerase sigma factor rpoD), RecN (DNA repair protein
recN), ThiC (thiamine biosynthesis protein ThiC), CydD (Transmembrane ATP-binding
protein ABC transporter) and SdaA (L-serine dehydratase) are connected to 10, 4, 8, 5, 5
and 4 human proteins, respectively.
The “database-array” interaction network also has smaller subnetworks containing human
proteins known to be relevant to tuberculosis infection. These proteins are JAK1, RAB5A,
RAB5C, CTSD and CALM1. RAB5A (Ras-related protein Rab-5A), RAB5C (Ras-related
protein Rab-5C) and CALM1 (Calmodulin) are all involved in the formation of the phagolyso-
some. CTSD (cathepsin D) is a protease secreted by the phagolysosome for bacterial degra-
dation.
2.3.7 Connections between “interolog-array” and “database-array”
interactions
In this section, we checked whether there are any common interactions shared by the two
sets of host-pathogen interactions “interolog-array” and “database-array”. There were no
common interactions between the two networks. However, there were proteins shared by
the two sets: 3 human proteins and 9 Mtb proteins (Figure 2.10). The shared human
proteins are MAT2A (S-adenosylmethionine synthase isoform type-2 ), AK2 (Adenylate
kinase 2, mitochondrial) and CAPZB (F-actin-capping protein subunit beta). The common
Mtb proteins are DnaB (replicative DNA helicase), RlmN (Ribosomal RNA large subunit
methyltransferase N), Upp (Uracil phosphoribosyltransferase), SecA1 (Protein translocase
subunit SecA 1), RpoD (RNA polymerase sigma factor RpoD), TopA (DNA topoisomerase
1), GlnE (Glutamate-ammonia-ligase adenylyltransferase), LigA (DNA ligase) and SerA (D-
3-phosphoglycerate dehydrogenase).
2.3.8 Discussion and conclusions
In this chapter, we constructed human and Mtb protein networks from various data. We
retrieved 48 known host-pathogen interactions from the literature, and used the interolog
method to predict host-pathogen interactions. 483 host-pathogen interactions were found
by using intra-species interactions as a prediction method. We filtered the interologs using
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Figure 2.10: Common proteins between “interolog-array” and “database-array” interactions.
Pink and blue nodes represent Mtb and human proteins, respectively. Orange nodes are the
common Mtb proteins, and green nodes are the common common proteins. Dashed and solid
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2) whether they are expressed during infection (the “interolog-array” interactions) . The
first filter gave 3 inter-species interactions whereas the second filter gave 78 inter-species
interactions.
The interaction between EPRS (human) and RecA (Mtb) was predicted by both the “interolog-
known” and “interolog-array”, therefore increasing the confidence of the interaction. The
inter-species interaction EPRS/RecA (P0A5U4) is the interolog of the intra-species inter-
action ProS/RecA (P78014) in M. pneumoniae M129. ProS is a proline-tRNA ligase. The
interaction in M. pneumoniae M129 was experimentally verified by tandem-affinity purifica-
tion [62].
We also used experimentally verified inter-species interactions from HPIDB and PATRIC
to predict human-Mtb interactions. This approach yielded 866 inter-species interactions be-
tween 644 human and 204 Mtb proteins. These interactions were filtered based on their
expression during tuberculosis infection. The resulting 109 interactions between 85 human
proteins and 53 Mtb proteins were called the “database-array” interactions. There was no
direct overlap between the “interolog-array” and “database-array” interactions. Neverthe-
less there were 3 human and 9 Mtb common proteins between the two sets of predicted
interactions. We noted that there were no overlap between these two sets of interactions
and the known host-pathogen interactions. A summary of the interactions in this chapter is
presented in Table 2.8.
Number of proteins Number of interactions
Human network 16,548 334,070
Mtb network 4,070 38,049
Known interactions 14 human proteins 48
25 Mtb proteins
Interolog-known 3 human proteins 3
3Mtb proteins
Interolog-array 35 human proteins 78
47 Mtb proteins
Database-array 85 human proteins 109
53 Mtb proteins
Table 2.8: Summary of the constructed networks and predicted interactions.
Though we used known interactions and microarray data to narrow down the interactions,
it was important to put the interactions in their biological context to see if they are likely











Analysis of predicted host-pathogen
interactions
In the previous chapter, we constructed a human and Mtb protein network and predicted
inter-species interactions between the two organisms using the interolog method. This yielded
a total of 483 host-pathogen interactions involving 175 human and 192 Mtb proteins. We
applied two filters to find interactions relevant to tuberculosis infection. The first filter
consists of the interologs where both proteins are neighbours of known proteins that we
called “interolog-known” interactions. The second filter consists of the interologs where both
proteins are differentially expressed during infection according to the microarray data from
Bossi and Lehner. We called these in eractions “interolog-array”. The two filters allowed us
to retrieve 3 and 78 interactions, respectively. We also predicted inter-species interactions
using experimentally verified host-pathogen interactions that we called “database-array”
interactions. We retrieved 109 such interactions. In this chapter, we shall focus on the
“interolog-known”, “interolog-array” and “database-array” interactions by analysing some
features of the predicted interactions, including their subcellular locations, GO biological
processes and their pathways.
3.1 The Gene Ontology
With the large increase in genomic data, there is a great need to represent and process infor-
mation about genes, their products and their functions across all species in a standardized
way. For this reason, the Gene Ontology (GO) consortium has developed a set of structured,
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GO is divided into three ontologies describing molecular functions (MF), biological processes
(BP) and cellular components (CC).
Molecular function describes the function of a gene product at a molecular level. The func-
tions of a gene product are the jobs that it performs and may include transporting things
around the cell, binding, holding things together and converting one molecule into another.
Catalytic activity and protein binding are examples of molecular function.
A biological process is defined in GO as a “series of events accomplished by one or more
ordered assemblies of molecular functions”. A process has a defined beginning and end.
Biological process terms can be quite specific (pyrimidine metabolic process or alpha-glucoside
transport) or very general (signal transduction or cellular physiological process). A biological
process is generally distinguished from molecular function by the fact that processes must
have more than one distinct step.
Finally, a cellular component describes locations of the gene product, which can be subcellu-
lar structures (nucleus or nuclear inner membrane) or macromolecular complexes (ubiquitin
ligase complex or ribosome). Extracellular environments of cells are also included in the
cellular component ontology.
Ontologies in GO are structured as directed acyclic graphs (DAGs) in which terms repre-
sent the nodes and arcs represent the relations between the terms. Therefore, terms have
parent-child relationships, with child terms being more specific or specialized than their re-
spective parent(s). For example, in the cellular component ontology, centrosome is a child
of intracellular non-membrane bounded organelle, which is in turn a child of organelle. The
relations between GO terms comprise is a; part of ; and regulates, negatively regulates and
positively regulates (http://www.geneontology.org/GO.ontology.relations.shtml).
The is a relation in GO means subtype. For example, if we say mitotic cell cycle is a cell
cycle, it means mitotic cell cycle is a subtype of cell cycle. The is a relation is transitive,
that is to say if A is a B and B is a C, then A is a C.
The part of relation is described as follows: if B is part of A, then if B exists, A necessarily
exists and B is part of A. However, the existence of A does not necessarily imply the existence
of B. For example replication fork is part of chromosome, means all replication forks are part
of some chromosome, but only some chromosomes have a part replication fork. Like the is
a relation, the part of relation behaves transitively.
The regulates, positively regulates and negatively regulates relations denote biological regu-
lation.
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• integrating protein information from different organsims
• assigning functions to protein domains
• finding functional similarities in genes that are coexpressed under certain conditions
• predicting the likelihood that a particular gene is involved in diseases that haven’t yet
been mapped to specific genes
• developing automated ways of deriving information about gene function from the lit-
erature
• verifying models of genetic, metabolic and product interaction networks.
AmiGO (http://amigo.geneontology.org/cgi-bin/amigo/go.cgi), developed by the GO
consortium, is the official web-based toolset for searching and browsing the Gene Ontol-
ogy database [29]. QuickGO, developed by the European Bioinformatics Institute (EBI),
also provides web-based access to the GO database [16]. However, while AmiGO and
QuickGO are good for accessing small datasets, the Gene Ontology Annotation (Uniprot-
GOA) Database [25], also developed by EBI, is better fitted to large data and provides
high-quality Gene Ontology (GO) annotations to proteins in the UniProt Knowledgebase
(UniProtKB). The GOA database can be accessed at http://www.ebi.ac.uk/GOA/.
We used GO to assess the functions of interacting proteins and to determine whether it is
biologically possible for our predicted interactions to take place. For example, within an
organism if two proteins share the same location (using the GO cellular component), they
are likely to interact, and across organisms, the interacting proteins must have the potential
to encounter each other.
3.2 Cellular component analysis
Protein interactions are constrained by physical location, meaning that two proteins can
interact only if they have the appropriate subcellular location.
In order to find the location of the human and Mtb proteins, we used their GO cellular com-
ponent terms. We converted these to GO slim terms associated with the cellular component
instead of the full GO cellular component ontology. GO slims are truncated versions of the
GO ontologies where the more specific terms are mapped to one or more high-level terms.
GO slims may be user defined or predefined by the GO Consortium GO slims. The “Investi-
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was used to find the GO slim cellular component terms of the proteins. The tool has three
main parts: “Choose Terms”, “Refine Selection” and “Find Annotations”. In the “Choose
Terms”, we choose the GO slim set we want to use. We can directly select one of the prede-
fined GO slims created by groups in the GO consortium. The “Add terms” text box allows
us to create a customised version of the predefined GO slim sets or create a new GO slim
set by adding GO identifiers in the text box. In the “Refine Selection”, we can remove a
GO term from the set we have chosen or remove all terms in a particular category (BP, MF
or CC). In our case, we removed the biolocal process and molecular function category and
only kept the cellular component category. Finally, the “Find Annotations” displays the
annotations of the proteins related to our GO slim set. However, it displays all the proteins
in UniProt. Unwanted proteins can be filtered out by choosing the “Filter” feature. Several
parameters, such as sequence identifier, taxon, or GO ID can be used as filters.
For the human proteins, we used the GO slim Generic, which is a predefined GO slim set.
The set is not species specific but it has many terms pertaining to eukaryotic organisms.
The set contains 35 cellular components terms. We used all the protein IDs of the human
network to filter the annotation. We then downloaded the results and collected the GO
cellular components that we divided into three groups: intracellular, membrane and secreted.
We also have the unknown category containing proteins that have no cellular component
annotation. The intracellular group contains the terms referring to all components inside of
the cells. The membrane group only contains the plasma membrane and the secreted group
contains the proteins in the extracellular region. Since a protein may be annotated to more
than one group, we set the final annotation of the protein as the furthest it can go outside
the cell. The repartition of the human protein locations is presented in Figure 3.1a. The
intracellular proteins form about half of the proteins, around 21% of the proteins are found
in the membrane, 12.14% are secreted and 12.65% of the proteins have unknown locations.
We used only the GO slim terms relevant to prokaryotes in the GO slim generic to build
the GO slim terms for the Mtb proteins and we used all the protein IDs of the Mtb network
to filter the annotation. In the case where the protein had no subcellular location, we
used PSORTb to predict its location, which was the case for 2272 proteins. PSORTb is a
web-based tool for prediction of subcellular location in bacterial protein sequences [150]. To
predict subcellular location using PSORTb, we first downloaded the FASTA sequences of the
proteins from UniProt. The FASTA file was then used as input to PSORTb. The parameters
of PSORTb were set as follows: the organism type was set to bacteria and the Gram stain was
set to positive. The result was a tab-delimited file containing the sequence ID of the protein,
the final prediction of localization and the score, each line representing one protein. The






















Figure 3.1: Repartition of human and Mtb proteins in the different localizations
“Cellwall”, “Extracellular” and “Unknown”. We used these locations to divide the predicted
locations into 5 main categories, from the inside of the cell to the outside: cytoplasm, cell
membrane, cell wall, secreted and unknown. Secreted proteins are proteins secreted into
the cell surroundings and proteins whose locations could not be identified were classed as
“unknown”. Again, if a protein was annotated by GO with more than one location, then we
took the one that is furthest from the inside of the cell. The repartition of locations for Mtb
is shown in Figure 3.1b.
3.2.1 Mtb protein subcellular locations
M. tuberculosis is a prokaryotic cell, it does not have a nucleus or membrane-bound or-
ganelles. An Mtb cell consists of:
• a peptidoglycan cell wall enclosing a cytoplasmic membrane or cell membrane, which
consists of a lipid bilayer with embedded proteins,
• a cytoplasm containing proteins and genetic material,
• external structures such as flagella and pili.
Table 3.1 shows the number of proteins in each subcellular location for the Mtb proteins
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interactions. Mtb proteins located in the cytoplasm are not likely to interact with host pro-
teins unless the Mtb cells are lysed, whereas proteins located in the cell membrane and those
which are secreted are more likely to interact with host proteins.
Subcellular location Known Interolog-known Interolog-array Database-array
Cytoplasm 0 1 8 9
Cell membrane 4 1 19 28
Cell wall 5 1 15 8
Secreted 16 0 5 8
Unknown 0 0 0 0
Table 3.1: Number of proteins in the 5 subcellular locations for Mtb proteins involved in the
known, “interolog-known”, “interolog-array” and “database-array” interactions
3.2.2 Human protein subcellular location
Unlike Mtb, human cells are eukaryotic cells, which have more complex inner structures than
prokaryotic cells. They contain membrane-bound compartments, called organelles, which
serve specific functions such as energy production and protein synthesis. The nucleus is
perhaps the most important among the eukaryotic organelles because it is the location of a
cell’s DNA. Figure 3.2 represents an animal eukaryotic cell with its various organelles and a
summary of the locations of interacting human proteins is provided in Table 3.2.
Subcellular location Known Interolog-known Interolog-array Database-array
Intracellular 1 2 29 45
Membrane 6 1 4 23
Secreted 7 0 0 12
Unknown 0 0 2 5
Table 3.2: Number of interacting human proteins in the intracellular, membrane, secreted
and unknown categories for proteins involved in the known, “interolog-known”, “interolog-
array” and “database-array” interactions
As seen in Table 3.2, all but one of the human proteins involved in known interactions are
located in the membrane or are secreted. The known interactions are generally derived
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Figure 3.2: Organelles of an animal eukaryotic cell (http://www.uvm.edu/~inquiryb/
webquest/fa06/mvogenbe/Animal-Cell.jpg).
dendritic cells. On the other hand, almost all the human proteins predicted to interact with
Mtb proteins are located within the cell. This could be explained by the fact that these
proteins are expressed during infection of macrophages and dendritic cells by Mtb, therefore
the mycobacteria is located within the cell and is likely to interact with proteins that are
intracellular.
3.2.3 Host-pathogen protein subcellular location
After looking at the protein locations from the host and the pathogen individually, we
analysed the locations of the host-pathogen protein pairs. Table 3.3 shows the localization
of the host-pathogen protein pairs.
As seen in Table 3.3, for the known host-pathogen protein interactions, the human proteins
are located in the membrane or secreted; and the Mtb proteins are located in the cell mem-
brane, cell wall or secreted. This is in agreement with the studies the interactions come
from, which focus on the recognition of Mtb by human receptors which are located on the
cell surface. The Mtb proteins are also located on the cell surface to enable binding to the
human receptors. One exception is the interaction between the human heat shock protein 40
(HSP40) and the Mtb antigen mpt64. The human protein is annotated as intracellular and
the bacterial protein is annotated as secreted, which is in accordance with [32], co-localizing










3.2. Cellular component analysis 53
Mtb is an intracellular pathogen that has evolved strategies to survive in intracellular phago-
somes. A study by van der Wel et al. shows that after two days of infection, Mtb progres-
sively translocates from phagolysosomes into the cytosol in nonapoptotic cells [135]. There-
fore, the likely locations of the host-pathogen protein pairs are intracellular-cell-wall/cell-
membrane/secreted if the pathogen is within the host cell, or secreted-cell-wall/cell-membrane/-
secreted if the pathogen just encounters the host cell.
In addition, although GO and PSORTb predicted some of the interacting Mtb proteins to
be cytoplasmic, annotation for some, ScoB, Glpk and GadB, for example, suggests that
these proteins have been identified by mass spectrometry in the membrane fraction of Mtb
cells. Therefore the subcellular location analysis provides us with more biological insight












Intracellular Secreted 1 0 9 8
Intracellular Cytoplasm 0 1 13 5
Intracellular Cell membrane 0 1 23 35
Intracellular Cell wall 0 0 22 11
Membrane Cell membrane 5 0 1 23
Membrane Cytoplasm 0 0 0 3
Membrane Cell wall 2 1 5 4
Membrane Secreted 10 0 1 1
Secreted Cytoplasm 0 0 0 5
Secreted Cell membrane 6 0 0 7
Secreted Cell wall 3 0 0 0
Secreted Secreted 21 0 0 1
Unknown Cytoplasm 0 0 0 1
Unknown Cell membrane 0 0 2 3
Unknown Cell wall 0 0 2 2
Table 3.3: Number of proteins in each host-pathogen location pair for proteins involved in
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3.3 Gene ontology term enrichment
To gain insight into the biological processes of the proteins involved in host-pathogen in-
teractions, we perform a GO term enrichment analysis using the DAVID (Database for An-
notation, Visualization and Integrated Discovery) Functional Annotation Chart tool (http:
//david.abcc.ncifcrf.gov/). A GO term enrichment analysis is used to highlight the
most relevant GO terms associated with a given gene list compared to the genes from which
the list is derived, known as the background. DAVID uses a modified Fisher’s exact p-value,
called EASE score, to calculate the enrichment p-value [63]. In order for DAVID to compute
a GO term enrichment analysis, it needs a gene list for which we want to see the enrichment
and a background list. Next, the annotation categories of interest have to be selected. In our
case, we chose the Gene Ontology category, more particularly the GO biological process cat-
egory as we want to perform a GO biological process term enrichment. For each protein list
of interest (“interolog-array” or “database-array” proteins), we performed a GO biological
process enrichment analysis using the human proteins or Mtb proteins from our constructed
network as background. As suggested on the DAVID website, we selected the GO terms
situated in the fourth and fifth level to avoid very gen ral GO terms such as “biological
process”. We used the Bonferonni p-value, which is a corrected p-values for multiple testing,
and we selected those GO terms enriched in our candidate protein list by requiring a p-value
less than 0.05.
The human “interolog-array” proteins predicted to interact with Mtb proteins were en-
riched in nitrogen compound biosynthetic process, oxoacid metabolic process, carboxylic
acid metabolic process and nucleobase, nucleoside and nucleotide metabolic process. When
Mtb cells are phagocytozed they are exposed to nitric oxide and oxidative stress. The inter-
acting human proteins may be involved in facilitating this. On the other hand, the human
proteins predicted using databases are enriched in processes related to negative regulation
of apoptosis and positive regulation of cellular process (Table 3.4). It is known that virulent
Mtb strains inhibit apoptosis of the host macrophage to protect their replicative niche [76].
For the Mtb proteins, the smallest Bonferonni corrected p-values were 0.100316 and 0.345477
for the “interolog-array” and “database-array”, respectively, meaning that we have insuffi-
cient evidence to support the claim that our gene list is enriched in any GO biological pro-
cesses. Nevertheless, when looking at the individual proteins, some of them share the same
biological processes with Mtb proteins known to interact with human. These proteins and
their GO terms are presented in Table 3.5. The biological processes include those particu-
larly relevant to the intracellular environment of Mtb in the host, such as growth of symbiont










3.3. Gene ontology term enrichment 55




GO:0044271 Nitrogen compound biosynthetic
process
9 1.04×10−6 0.000238
GO:0043436 Oxoacid metabolic process 9 5.42×10−5 0.012279
GO:0019752 Carboxylic acid metabolic process 9 6.52×10−5 0.014697
GO:0055086 Nucleobase, nucleoside and nu-
cleotide metabolic process
7 1.19×10−4 0.026762
GO:0048522 Positive regulation of cellular pro-
cess
27 2.03×10−5 0.012038
GO:0042981 Regulation of apoptosis 17 2.19×10−5 0.014412
GO:0043067 Regulation of programmed cell
death
17 2.47×10−5 0.01462
GO:0010941 Regulation of cell death 17 2.59×10−5 0.015313
GO:0043066 Negative regulation of apoptosis 11 6.10×10−5 0.035683
GO:0043069 Negative regulation of programmed
cell death
11 6.88×10−5 0.040119
GO:0060548 Negative regulation of cell death 11 7.04×10−5 0.041059
Table 3.4: Enriched GO biological process terms in human “interolog-array” proteins (top)
and human “database-array” proteins (bottom).
immune response, and pathogenesis. Proteins playing a role in these processes may achieve
their goal in protecting the pathogen from the environment through interaction with host
proteins.
Furthermore, 32 and 22 proteins from the “interolog-array” and the “database-array” Mtb
lists, respectively, were among the essential genes required for growth identified by Sassetti
et al. using transposon site hybridization (TraSH) [116]. The genes in Sassetti et al. were
initially for Mtb H37Rv but the orthologue file from INTEGR8 allowed us to map them to
CDC1551 genes. In particular, 3 “database-array” proteins are also virulence factors of Mtb,
namely NarG (O06559), RelA (P66014) and MbtB (P71717). NarG is a nitrate reductase.
Nitrate respiration helps the bacteria to survive in O2-depleted areas of inflammatory or
necrotic tissue. NarG interacts with the human protein sorting nexin SNX6 (Q9UNH7),
which is thought to be involved in several stages of intracellular trafficking. RelA is a pro-
tein that coordinates the metabolism of (p)ppGpp, a mixture of 3’-pyrophosphate derivative
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UniProt Acc Protein name GO ID GO name
O53832 PstB1 GO:0035435 phosphate ion transmembrane transport
GO:0044117 growth of symbiont in host
P0A558 Tuf GO:0001666 response to hypoxia
GO:0006184 GTP catabolic process
GO:00100039 response to iron ion
P0A602 RpoD GO:0009405 pathogenesis
GO:0009415 response to water
GO:0052572 response to host immune response
P63288 ClpB GO:0006950 response to stress
GO:0009408 response to heat
P63650 ScoB GO:0001666 response to hypoxia
P63852 CtaD GO:0009060 aerobic respiration
P64411 HtpG GO:0006950 response to stress
GO:0071451 cellular response to superoxide
P69942 GlnE GO:0040007 response to ammonium ion
O53306 FadD13 GO:0001101 response to acid
GO:0044119 growth of symbiont in host cell
P63393 IrtB GO:0009405 pathogenesis
O53189 Tig GO:0006457 protein folding
GO:0009267 cellular response to starvation
GO:0046677 response to antibiotic
O06559 NarG GO:0001101 response to acid
GO:0001666 response to hypoxia
P95095 CstA GO:0009267 cellular response to starvation
P66014 RelA GO:0009405 pathogenesis
P71717 MbtB GO:0009405 pathogenesis
GO:0052572 response to host immune response
Q50723 Rv3402c GO:0052572 response to host immune response
P0A602 RpoD GO:0009405 pathogenesis
GO:0052572 response to host immune response
Table 3.5: Important GO biological processes of Mtb “interolog-array” proteins (top) and
“database-array” proteins (bottom)
tions, such as nutrient starvation, RelA produces (p)ppGpp that accumulates intracellularly
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pression of genes involved in DNA replication [105]. RelA was predicted to interact with
the human protein CALCOCO1 (Q9P1Z2). CALCOCO1 is thought to be involved in ele-
mentary cellular functions linked to Ca2+/calmodulin signaling [129]. Finally, MbtB, also
known as mycobactin synthetase protein B, is involved in the initial steps of the mycobactin
biosynthetic pathway. Mycobactins are lipophilic siderophores of mycobacteria mediating
iron acquisition within macrophages [82]. MbtB interacts with the human proteins stabilin-
1 STAB1 (Q9NY15) and cofilin-1 CFL1 (P23528). Stabilin-1 is a scavenger receptor and
binds to both Gram-positive and Gram-negative bacteria [1] whereas cofilin-1 is a 18kDa
phosphoprotein that regulates actin cytoskeleton dynamics.
3.4 GO biological process similarity score
We also functionally compared predicted human-Mtb protein pairs by computing their GO
biological process similarity. Semantic similarity measures allow us to compare similarities
between proteins based on their annotations [103]. We used the GO-universal metric based
on the GO-DAG topology to compute the biological similarity between two proteins [86].
For each pair of proteins involved in a predicted host-pathogen interaction, we computed the
similarity between their GO annotations. For each protein participating in the host-pathogen
interactions, we also computed the similarity between that protein and all its neighbours.
Table 3.6 represents the similarity score for each host-pathogen interaction list.
On average, the inter-species interactions have a low functional similarity, particularly com-
pared to the similarity scores between intra-species neighbours. For the known host-pathogen
interactions, two interactions have a similarity score of 0. The interactions are between the
Mtb antigen 85-A and the human proteins fibronectin and plasminogen. In the “database-
array” interactions, 7 host-pathogen interactions had a similarity score of 0. These interac-
tions are listed in Table 3.7.
However, two inter-species interactions have a high functional similarity as is the case of the
“interolog-array” interaction between AARS (P49588) and GltX (P0A636), which has the
maximum similarity score among the “interolog-array” interactions. AARS is a cytoplasmic
alanine–tRNA ligase whereas GltX is a glutamate–tRNA ligase. The interactions between
TLE4 (Q04727), a transducin-like enhancer protein 4, and Mfd (P64326), a transcription-
repair-coupling factor, has the highest similarity score among the “database-array” inter-
actions. Apart from these cases, it is perhaps not surprising that inter-species interactions
would have lower similiarity scores, as these interactions are more likely to be between pro-

















Minimum 0.0957 0.00104 0.0
Mean 0.2781 0.24062 0.10190
Maximum 0.4389 0.75508 0.33847
Minimum 0.3129 0.2944 0.06425
Mean 0.3527 0.3885 0.11012
Maximum 0.3934 0.5704 0.13411
Minimum 0.08021 0.1545 0.00638
Mean 0.31987 0.3743 0.24065
Maximum 0.61023 0.6846 0.76297
Minimum 0.03812 0.003152 0.0
Mean 0.30295 0.334651 0.08372
Maximum 0.74204 0.65133 0.62843
Table 3.6: Similarity scores for the various lists of host-pathogen interactions. The first row
is for the known interactions, the second row for the “interolog-known”, the third row for
the “interolog-array” and the last row for the “database-array” interactions.
3.5 Pathways
Bacterial pathogens attack intracellular-signalling and cytoskeletal pathways to alter host
responses in a way that benefits them. For example, Mtb interferes with the NF-κB and the
MAPK signalling pathways leading to the prevention of NF-κB dependent transcription and
the alteration of antigen presentation, respectively (see 1.3.3). Bacteria might also hijack
host metabolic pathways. For instance, Chlamydia pistacci hijacks the host’s tryptophan
depletion pathway by intercepting the byproduct kynurenine, which is used by C. pistacci
to produce its own tryptophan [49].
We used the Kyoto Encyclopedia of Genes and Genomes (KEGG) to find pathways that
the predicted proteins belong to. The KEGG Mapper-Search and Color Pathway mapping
tool allows us to search given objects, such as genes, proteins or compounds against KEGG
pathways maps. For each list of predicted proteins (human and Mtb, “interolog-array” or
“database-array”), we obtained a list of pathways relevant to the protein list. However,
not all proteins belong to a pathway and a protein may be part of several pathways. For
each human-Mtb protein interaction with both proteins belonging to one or more pathways,













Human protein name Mtb UniProt
Acc
Mtb protein name
P08133 ANXA6, annexin A6 P66753 RuvB, Holliday junction
ATP-dependent DNA heli-
case








O75882 ATRN, attractin P65499 NadB, L-aspartate oxidase
O75882 ATRN, attractin Q10628 Rph, ribonuclease PH
P46939 UTRN, utrophin O06414 MenB, DHNA-CoA syn-
thase
O75629 CREG1, Cellular repressor






Q10628 Rph, ribonuclease PH
Table 3.7: The “database-array” interactions having a similarity score of 0.
tuberculosis infection.
By applying this method, we were able to reconstruct a small network centered on the
human MAT2A protein (Figure 3.3). MAT2A catalyzes the reaction from L-methionine to
S-adenosyl-L-methionine in the cysteine and methionine metabolism. MAT2A was predicted
to interact with 10 Mtb proteins in total. 3 of these proteins, namely MetK, RlmN and ThiC,
have direct links to L-methionine or S-adenosyl-L-methionine in metabolic pathways. MetK
is a methionine adenosyltransferase and performs the same function as MAT2A. RlmN is
a ribosomal RNA large subunit methyltransferase N and specifically methylates position 2
of adenine 2503 in 23S rRNA. Finally, ThiC is a hydroxymethylpyrimidine phosphate syn-
thase catalyzing the synthesis of the hydroxymethylpyrimidine phosphate (HMP-P) moiety
of thiamine from aminoimidazole ribotide (AIR) in a radical S-adenosyl-L-methionine depen-
dent reaction. ThiC is an essential gene necessary for thiamin (vitamin B1) synthesis [115].
Two proteins interacting with MAT2A, namely Dxs and ScoB, belong to pathways using

































Figure 3.3: Interaction involving MAT2A. Thin arrow indicates direct interaction, whereas
thick arrow indicates that there are several steps.
which is consumed during the biosynthesis of the thiazole moiety of thiamin. ScoB is the B
subunit of probable succinyl-CoA:3-ketoacid-coenzyme A transferase.
We also looked at host-pathogen interactions where both proteins belong to the same path-
way but Mtb does not have the equivalent of the human protein in its pathway. The human
protein GOT2 (P00505), an aspartate aminotransferase, mitochondrial, interacts with the
Mtb protein Rv0458 (P63937), which is a probable aldehyde hydrogenase. Both proteins are
involved in arginine and proline metabolism but the Mtb pathway lacks the aspartate amino-
transferase protein. Two interactions, the first between human protein SUCLA2 (Q9P2R7,
EC:6.2.1.4) and Mtb SucD (P71558, EC:6.2.1.5) and the second between human protein SU-
CLG1 (P53597, EC:6.2.1.4, 6.2.1.5) and Mtb SucC (P71559, EC:6.2.1.5), have all proteins
belonging to the citrate cycle (TCA) pathway. The two human proteins catalyse the ligation
of succinate and CoA to form succinyl-CoA, the ligation is ATP-dependent for SUCLA2 and
ATP- or GTP-dependent for SUCLG1. However, Mtb only possesses the enzyme with EC
number 6.2.1.5, which is the succinate–CoA ligase (ADP-forming). These could represent
examples of Mtb possibly using host proteins or products of their reactions to complete its
pathways.
Interestingly, the first pathway retrieved while searching the human “database-array” pro-
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NFKB1, RAB5A, RAB5C, CALM1 (P62158) and CD74, were mapped onto the tuberculosis
pathway. In particular, CTSD, RAB5A, RAB5C and CALM1 are all involved in phago-
some maturation which is blocked by Mtb. CALM1 is a Ca2+-dependent effector protein
necessary for the activation of CaMKII, which is required for the recruitment of EEA1 to
the phagosome. RAB5A and RAB5C are GTPases necessary for phagosome maturation
through the recruitment of a large number of effector proteins. Lastly, CTSD or cathepsin
D is a hydrolytic protease secreted by the phagolysosome for bacterial degradation. Figure
3.4 represents the proteins highlighted on the tuberculosis pathway from KEGG.
While searching the Mtb proteins “interolog-array” or “database-array” against KEGG, one
protein from “interolog-array”, namely GroEL (P0A520), belongs to the tuberculosis path-
way. GroEL (HSP65, highlighted in Figure 3.4) is a 60 kDa chaperonin 2 protein known to
interact with TLR4. In the “interolog-array” data, it was predicted to interact with three
human proteins: CLPP (Q16740), a putative ATP-dependent Clp protease proteolytic sub-
unit, mitochondrial, TUFM (P49411), an elongation factor Tu, mitochondrial, and PRPS2
(P11908), which is a ribose-phosphate pyrophosphokinase 2. Even if the other Mtb proteins
did not map to the tuberculosis pathway, some of them have biological processes that are
present in the known Mtb proteins interacting with human proteins (Table 3.5). Metabolic
pathways, biosynthesis of secondary metabolites and microbial metabolism in diverse envi-
ronments are the top three pathways the “interolog-array” and “database-array” proteins
map to.
3.6 Predicted interactions and drug targets
One of the main reason to study host-pathogen protein interactions is the possibility of
finding targets to create new drugs. This is particulary important in the case of tuberculosis
because of the existence of drug resistance.
A list of 881 potential drug target proteins was computationally predicted for the Mtb net-
work in a separate study in the laboratory [84]. These are important proteins in the Mtb
functional network since they are responsible for several indirect functional connections be-
tween other proteins in network. 878 out of 881 proteins were present in our Mtb network.
We used this list to identify potential drug targets in the Mtb proteins predicted to interact
with human proteins and we used the Fisher’s exact test to determine whether the predicted
list of proteins contains more drug targets than by chance. Table 3.8 presents the number of
drug targets in each Mtb protein list with the p-value given by the Fisher’s exact test. Taking
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tain more drug targets than would be expected by chance, with p-values of 2.41×10−6 and
3.80×10−5, respectively. Figures 3.5 and 3.6 highlight the Mtb proteins drug targets in the
“interolog-array” and “database-array” interactions, respectively. 5 of the human proteins
from the “database-array” interactions that mapped onto the tuberculosis pathway interact
with Mtb proteins predicted to be drug target. In particular, the 4 Mtb proteins interacting
with CD74 are all predicted drug targets.




Table 3.8: Number of drug targets and p-value for each Mtb protein list.
3.7 Discussion and conclusion
In this chapter, we analysed the predicted host-pathogen interactions to see if they are
likely to take place. In order to do so, we first looked at the subcellular localization of the
proteins using the GO cellular component. We noted that human proteins known to interact
with Mtb proteins are secreted or located in the membrane. Likewise, Mtb proteins known
to interact with human proteins are secreted, located on the cell wall or cell membrane.
Indeed, the known human-Mtb interactions come from studies focusing on the recognition
of Mtb proteins by human receptors, thus the surface localization of the proteins. On the
other hand, human proteins predicted to interact with Mtb proteins are mostly annotated as
intracellular, though several human proteins from the “interolog-database” are annotated as
membrane or secreted. Mtb proteins predicted to interact with human proteins are mostly
found on the cell membrane, cell wall or are secreted, only a few are located in the cytoplasm.
The subcellular locations of the predicted proteins reflect the fact that the bacteria is located
within the host cells and suggests that all of these predictions are potentially feasible.
We also performed a GO biological process term enrichment on the predicted proteins using
the DAVID web tools. The human “interolog-array” proteins predicted to interact with Mtb
proteins were enriched in nitrogen compound biosynthetic process, oxoacid metabolic pro-
cess, carboxylic acid metabolic process and nucleobase, nucleoside and nucleotide metabolic
process. The human “database-array” proteins predicted to interact with Mtb were enriched

























































































































































































































































































































































































































































































































































































































































































































































3.7. Discussion and conclusion 66
of programmed cell death and regulation of cell death. In particular, we had negative reg-
ulation of apoptosis, negative programmed cell death and negative regulation of cell death.
All of the three biological processes have the same 11 proteins, listed in Table 3.9 and they
interact with 21 bacterial proteins. Among these 11 human proteins, 5 interact with human
anti-apoptosis genes that are known to be upregulated during Mtb infection, namely MCL-1
(Q07820), Bfl1 (Q16548), FLIP (Q8NFZ5) and BCL-2 (P10415) [7, 19]. Mtb might therefore
interact with these proteins to inhibit apoptosis. These results are in accordance with the
fact that Mtb inhibits apoptosis of the host macrophage at the early stage of infection to
be able to survive and persist in the macrophages. Three Mtb proteins are known to inhibit
apoptosis during early infection: NuoG (P95175), which encodes one subunit of the type I
NADH dehydrogenase, PknE (P72001), a serine threonine kinase and SodA, a superoxide
dismutase which is not present in our Mtb network. However, SodA is secreted by SecA2
(P66785), a bacterial secretion system [19]. We found that SecA2 interacts with SecA1,
which in turn interacts with NFKB1, one of the human protein interacting with human
anti-apoptosis gene.
Uniprot Acc Protein name Gene name
Q99933 BAG family molecular chaperone regulator 1 (Bcl-2-associated
athanogene 1)
BAG1
O15519 CASP8 and FADD-like apoptosis regulator CFLAR
P10809 60 kDa heat shock protein, mitochondrial HSPD1
P10909 Clusterin CLU
P23528 Cofilin-1 (18 kDa phosphoprotein) CFL1
P14625 Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) HSP90B1
P04233 HLA class II histocompatibility antigen gamma chain CD74
P09601 Heme oxygenase 1 HMOX1
P19838 Nuclear factor NF-kappa-B p105 subunit NFKB1
P30048 Thioredoxin-dependent peroxide reductase, mitochondrial PRDX3
Q9NQB0 Transcription factor 7-like 2 (T-cell-specific transcription factor 4) TCF7L2
Table 3.9: Human proteins involved in apoptosis
When analysing the pathways the predicted proteins belong to, we found that the three
Mtb proteins MetK, RlmN and ThiC interacting with the human MAT2A protein use L-
methionine or S-adenosyl-L-methionine (SAM). Methionine is a key amino acid for protein
structure and for metabolism [20] and is mostly used to synthesize SAM, which is the prin-
cipal biological methyl donor [81]. Mtb was shown to import methionine from the host [88].
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uses methionine imported from the host to produce S-adenosyl-L-methionine. Mapping of
the human “database-array” proteins onto KEGG also retrieved the tuberculosis pathway.
In particular, 5 proteins were involved in phagolysosome fusion, which is blocked by Mtb
during infection.
Guérin and de Chastellier [58] proposed that M. avium impairs the movement of early en-
dosomes by disrupting the actin filament network. This reduces the probability of fusion
and intermingling of membrane and contents between the endosomes and phagosomes con-
taining this pathogenic mycobacterium. They hypothesise that M. avium disrupts the actin
filament network by direct interaction of bacterial constituents with proteins of, or associ-
ated with, the phagosome membrane being involved in depolymerization/polymerization of
actin filaments. Furthermore, they mentioned several host proteins, namely the actin motor
myosin-I, the actin binding proteins ezrin and moesin, the small GTPase of the Rho fam-
ily RhoD, and the bacterial macrophage-induced gene (mig) protein as potential candidates
for the disruption of the actin filaments. We predicted that both human proteins moesin
(P26038) and ARHGAP4 (P98171), which is a Rho GTPase-activating protein 4, interact
with the bacterial protein FtsZ (P64170), a cell division protein and prokaryotic homolog
of tubulin. An interaction between human MYO1E (Q12965), an unconventional myosin-I
which serves in intracellular movements, and LeuS (P67510), a leucyl-tRNA synthetase, was
also predicted.
The bacterial protein HtpG is a heat shock protein belonging to the 90-kDa molecular chap-
erone family. Heat shock proteins (hsp) are major antigens in a number of infectious diseases.
In particular, immune response to members of the Hsp90 family has been observed in schisto-
somiasis, malaria, Chaga’s disease and candidiasis. HtpG was predicted to interact with the
human protein CAPZB, which is a a F-actin-capping protein subunit beta. F-actin-capping
proteins bind in a Ca2+-independent manner to the fast growing ends of actin filaments
(barbed end) thereby blocking the exchange of subunits at these ends. CAPZB has actin
filament capping, which is a child of negative regulation of actin filament depolymerization,
as GO biological process. CAPZB was also predicted to interact with the bacterial protein
mfd (P64326), which is a transcription-repair-coupling factor.
Macrophages produce reactive nitrogen and oxygen intermediate to kill Mtb. Human ADH5
(P11766) or GSNOR is a S-nitrosoglutathione reductase which regulates S-nitrosothiols
(SNOs) and nitric oxide (NO) in vivo through catabolism of S-nitrosoglutathione [126],
more precisely it blocks NO function by reducing S-nitrosoglutathione (GSNO) to NH3 [65].
It is therefore an important protein in the control of NO metabolism. ADH5 was predicted
to interact with the Mtb pstB1 (O53832), which is a phosphate-import ATP-binding pro-










3.7. Discussion and conclusion 68
S-formylglutathione to formate and glutathione, which is toxic to mycobacteria [38]. EstD
was predicted to interact with two Mtb proteins: GlpK (O69664), a glycerol kinase and
SecA1 (P0A5Y8), which is a protein translocase subunit SecA 1.
Interestingly, the “interolog-array” and “database-array” Mtb proteins contain more poten-
tial drug targets than due to chance alone. These proteins would therefore be of great
importance for drug design provided that their role in host interactions were experimentally
confirmed.
Inter-species protein interaction prediction using interologs is able to capture the fact that
Mtb is inside the host during infection. However, the GO biological processes and the
pathways are quite different depending on the initial data used to predict the interologs.
Nonetheless, the results are complementary since they give insight into how Mtb might












Host-pathogen protein interactions are essential for the pathogen to establish infection and
to be able to survive inside the host. However, experimental studies of these interactions are
scarce and computational methods are used instead to predict the interactions.
This project was set out in order to predict protein interactions between human and Mtb. We
used computational methods based on interologs to predict them and overlaid the predicted
interactions onto constructed human and Mtb protein interaction networks. The human
protein interaction network was constructed by integrating data from Bossi and Lehner, RE-
ACTOME and STRING. On the other hand, the Mtb network combined data from STRING,
gene expression and sequence data. We predicted interologs by using experimentally verified
intra-species and inter-species interactions, that were furthermore filtered using expression
data. We also collected already known host-pathogen interactions by literature mining and
found 47 interactions, which were subsequently used as a filter for the interologs predicted
using intra-species interactions to find the “interolog-known” interactions. We assessed the
likelihood that the predicted interactions would occur in vivo by looking at their cellular
components, biological processes and pathways. The Mtb proteins were located on the cell
surface, whereas human proteins were mostly tagged as intracellular, showing the intracel-
lular location of the bacteria. Analysis of the biological processes of the proteins suggests
that the human “interolog-array” proteins are involved in facilitating the production of nitric
oxide whereas the “database-array” proteins are related to negative regulation of apoptosis.
Predicted host-pathogen interactions had very low function similarity score suggesting that
interacting human and Mtb proteins perform different functions. Mapping the predicted
interactions onto KEGG pathways revealed that some of the proteins are known to play a
role in tuberculosis and that Mtb might hijack the host to acquire nutrients. We also found











Human-Mtb interaction prediction is of great importance for understanding tuberculosis.
Our work predicts interactions that could help understand the interplay between the host
and pathogen and may prove useful for designing new drugs. However, all predictions should
ideally be verified in the laboratory, and technologies are now available for experimental
identification of inter-species protein interactions [111, 136]. In future work, in addition
to experimental validation, the interologs method used here could be combined with other
computational protein-protein interaction prediction methods to improve the results. These
include the use of knowledge on interacting domains. Future work could also include applying
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